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The highly basic 55 amino acid nucleocapsid protein (NC) that coats the HIV-1 genome
has two zinc fingers that differ by five amino acids (strain pNL4-3). Previous work showed
that NC’s first finger (N-terminal) is primarily responsible for unwinding secondary
structures (helix destabilizing activity), while the second (C-terminal) plays an accessory
role. The amino acid differences between the fingers are (finger one to finger two):
phenylalanine to tryptophan (F to W), asparagine to lysine (N to K), isoleucine to glutamine
(I to Q), alanine to methionine (A to M), and asparagine to aspartic acid (N to D) at positions
16, 17, 24, 25, and 27 of finger one, respectively. To determine at an amino acid level the
reason for the apparent distinction between the fingers, five point mutants were designed
with amino acid residues in finger one incrementally replaced by those at corresponding
locations in finger two. Each mutant was analyzed in annealing assays with unstructured and
structured substrates. Three groupings emerged: (1) those similar to wild type (wt) levels
(N17K, A25M), (2) those with diminished activity (I24Q, N27D), and (3) mutant F16W
which had substantially greater helix destabilizing activity than wt NC. All mutants retained
wt levels of the condensation/aggregation activity of NC. Unlike I24Q and others, N27D was
defective in DNA binding. Only I24Q and N27D showed reduced strand transfer in in vitro
recombination assays. Double and triple mutants F16W/I24Q, F16W/N27D, and
F16W/I24Q/N27D all showed defects in DNA binding, strand transfer, and helix
destabilization, suggesting that the I24Q and N27D mutations have a “dominant negative”
effect and abolish the positive influence of F16W. Results show that amino acid differences
at positions 24 and 27 contribute significantly to finger one's helix destabilizing activity and
hence NC’s chaperone activity. Preliminary results from in vivo experiments indicated that
virus with the N27D mutation is infectious at near wt NC levels. This suggests that
aggregation activity may be more important than helix destabilizing for viral viability.
Results from two other forms of HIV-1 NC (NCp9 and NCp15) and NC proteins from Simian
Immunodeficiency Virus and Murine Leukemia Virus are also reported.
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Chapter 1 General Introduction
1.1 Introduction
Acquired Immunodeficiency Syndrome or AIDS is one the leading causes for worldwide
mortality since it was first reported in 1981. AIDS is caused by the Human
Immunodeficiency Virus or HIV which is a member of the retrovirus family (Retroviridae).
Retroviruses contain a highly divergent and large population of enveloped, positive sense
RNA viruses with several common features including viral replication, structure and
composition. They are so named because of a characteristic feature in their replication:
retroviruses make a double stranded DNA copy of their single stranded RNA genome,
contrary to the classical flow of genetic information from DNA to RNA. HIV belongs to the
Lentivirus genus, one of seven genera in the family. Lentiviruses are otherwise called slow
viruses primarily due to their slow growth and long asymptomatic period between initial
infection and appearance of detectable clinical symptoms [1]. A person is said to be suffering
from AIDS when he/she is in the most advanced stages of HIV infection. The Centers for
Disease Control (CDC) defines AIDS as a condition when the T4 lymphocyte count drops
below 200 per cubic millimeter of blood. CDC’s definition also encompasses to some 26
opportunistic infections which are otherwise harmless to healthy individuals [2]. During May
1983 Luc Montagnier and his co-workers at the Pasteur Institute in France reported that they
had isolated a new retrovirus associated with AIDS which they called Lymphadenopathy
Associated Virus (LAV). In April of the following year Dr. Robert Gallo of NCI reported
that his group had determined the causative agent of AIDS and named it Human T-
Lymphotropic Virus Type III (HTLV-III). Subsequently in June of that year, the two groups
announced that LAV and HTLV-III were almost identical. Two years later, the International
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Committee on Taxonomy of Viruses (ICTV) changed the name of the AIDS virus to Human
Immunodeficiency Virus (HIV) [3]. There are two main types of the virus, HIV-1 and HIV-
2. HIV-2 was first isolated in Cameroon in West Africa in 1985. It is less prevalent and
virulent than HIV-1, though still fatal. The genome of HIV-2 is very similar to SIV or Simian
Immunodeficiency Virus [4]. HIV-1 is by far the more predominant form worldwide. There
are three main groups of HIV-1: Group M or “Main” is highly predominant and is
responsible for more than 90% of infections worldwide. It is comprised of nine different
subtypes: A, B, C, D, F, G, H, J, K and various circulating recombinant forms (CRFs) that
were derived from recombination between subtypes. Previously, subtypes E and I were also
categorized under the M Group. The subtypes E and I are no longer designated as two pure
subtypes. They are now being referred to as CRFs. Genetic hybridization between subtypes
A and a “parent subtype E” is thought to have resulted in CRF A/E. A pure isolate of subtype
E has never been reported. Subtype I was initially so named when it was first isolated in
Cyprus. It was then reclassified as a CRF namely CRF A/G/I. It is now believed that this
virus represents an even more complex CRF resulting from recombination between subtypes
A, G, H and K. It has some unclassified genomic regions as well. Group O or “Outlier” is
comprised of strains other than the genotypes found in Group M. It is mainly found in west-
central Africa. Group N or “New” was first reported in 1998 in Cameroon and is extremely
rare [5].
1.2 AIDS prevalence and general epidemiology
Over the past couple of decades the AIDS epidemic has claimed millions of human lives
worldwide. According to the latest statistics released by UNAIDS/WHO in November 2005,
there are nearly 40.3 million people estimated to be living with HIV/AIDS in 2005, out of
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which 2.3 million are children. About five million people are believed to have been newly
infected last year. Further, 2005 saw the death of 3.1 million people due to AIDS. Since
1981, the AIDS pandemic has claimed nearly 25 million human lives worldwide. It is
estimated that around 6000 people worldwide get infected with HIV every day. Nearly 95%
of those living with AIDS reside in developing countries primarily due to poverty, poor
medical and sanitation facilities and a major lack in resources for HIV prevention and
treatment. This number is estimated to increase even further in the future. Some of the worst
struck areas include Sub-Saharan Africa and Latin America and Central Asia. Subtype B is
prevalent in the Americas and Western Europe, whereas A and C are predominant in the
African and Asian continents [6]. The following are the routes through which HIV infection
can spread:
1. Unprotected vaginal/anal/oral sex with an infected person. The infected individual
who harbors the virus in his/her sexual fluids can cause the virus to spread to his/her
partner. Oral sex poses a slightly lesser risk, although it is highly risky if a condom is not
used, and if one partner has an open cut in his/her mouth.
2. Through sharing of infected needles. This mode of transmission is very common
among injection drug users who share needles between themselves.
3. Through infected blood/blood products. This is highly prevalent when unscreened
blood/blood products are transfused from an infected individual to a non-infected one.
4. From mother to child. This could occur between an HIV-positive mother and her
child either during pregnancy/breast-feeding/child-delivery.
5. Exposure to an infected person’s blood. This would happen when sufficient blood
from an infected person enters the body of an uninfected one [7].
4
This global pandemic has currently reached epic proportions. Several international
organizations like UNAID, AVERT, WHO, CDC, CIPRA, and NIAID have joined hands in
the battle against AIDS. Despite the advent of several effective therapies, AIDS remains near
the top as a worldwide killer among infectious diseases. Only lower reparatory infections,
which are caused by many different viruses and bacteria, kill more people each year.
Obviously, we need to know as much as we can about the virus and it’s mode of replication
so that potential targets for drug therapy, viral inhibitors and vaccines can be determined.
1.3 Pathogenesis of HIV infection
HIV infects T4 lymphocytes or Helper T cells of the immune system. In a healthy
individual, upon infection and antigen presentation, activated T4 cells produce and secrete a
multitude of interleukins and cytokines in order to activate macrophages, natural killer cells,
CD8+ T cells and other cells of the immune system to fight the infection. There are
approximately 800-1200 T4 cells per mm³ of blood in a healthy person. As HIV invades the
helper T cells, over the course of several years (typically about 10) this number drops to a
staggering 200 or even lower. This leads to a profound immunosuppresion, and the
individual becomes highly susceptible to several opportunistic infections (OIs), cancers etc.
These include a wide range of fungal, bacterial, viral and protozoan infections which are
otherwise harmless in a healthy host [2]. Some of the symptoms seen early during an HIV
infection include: unexplained weight loss, fatigue, headache, recurrent diarrhea, seborrheic
dermatitis etc. During this stage the T4 cells are steadily being depleted. Usually the patient
is put on anti-retroviral therapy at this stage. The T4 cell count is an indicator of the level of
immune depletion in an AIDS patient. Some of the common OIs seen in AIDS patients when
the T4 cell count falls lower than 500 per mm³ of blood are candidiasis, Kaposi’s sarcoma,
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pulmonary tuberculosis, cryptosporidiosis, Herpes Zoster, pneumococcal pneumonia, and
oral hairy leukoplakia. Levels lower than 200 lead to Pnuemocystis carinii pneumonia (PCP,
the number one cause of death in AIDS patients), extra-pulmonary tuberculosis,
Toxoplasmosis and others. Infections caused due to Cytomegalovirus and Mycobacterium
avium are seen when the levels drop further down to 50 [8].
1.4 Anti-retroviral therapy
Unfortunately, to date there is no cure for AIDS or HIV infection. There are anti-
retroviral drugs available that reduce the viral load, slow down and possibly stop disease
progression. Currently, there are five classes of anti-HIV drugs approved by the FDA. They
are:
1. Nucleoside analog RT inhibitors (NRTI): These drugs were introduced in 1987.
They were the first group of anti-HIV drugs available to treat AIDS patients. These are a
class of drugs that interfere with the process of reverse transcription mediated by reverse
transcriptase (RT) enzyme. They are popularly known as “nukes” for nucleoside
analogues. They affect the synthesis of the growing viral DNA strand by competing with
normal nucleotides for binding to RT, then becoming incorporated into the growing
chain. The lack of an extendable 3’ hydroxyl group causes the chain to terminate. Some
examples of this class of drugs include lamivudine, abacavir, stavudine, zidovudine, and
didanosine.
2. Non-nucleoside analog Reverse Transcriptase inhibitors (NNRTI): These are
a class of drugs that are non-nucleoside analogues that also interfere with the reverse
transcription process, although they do so by binding non-competitively to RT.
Commonly known as non-nukes or non-nucleosides, these drugs came to the market
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around 1997. Some examples of NNRTI drugs include delavirdine, nevirapine and
efavirenz.
3. Protease inhibitors: These drugs inhibit the viral protease enzymes that function
later during viral replication. They were approved a couple of years before the NNRTI
drugs in 1995. The protease enzyme functions to cleave precursor proteins into functional
peptides. Defective protease enzymes or lack of protease function results in immature,
non-infectious virions with aberrant core morphologies. Examples of this class of drugs
include ritonavir, saquinavir, nelfinavir and indinavir.
4. Nucleotide Reverse Transcriptase Inhibitors (NtRTI): These function like the
NRTI drugs except that they are nucleotide analogues. They were approved in October of
2001 by the FDA. Tenofovir is one such example of a nucleotide analogue.
5. Fusion/entry inhibitors: This is the fifth and latest class of drugs that have been
recently approved in the US and Europe since 2003. Unlike the above three class of drugs
that interfere with the viral replication steps that occur after viral entry into the host, this
class of drugs acts against HIV prior to its entry into the cell. T-20 is an example of a
fusion inhibitor drug that binds to the membrane-spanning domain of the viral
glycoprotein polypeptide complex namely gp-41, thereby preventing it from fusing with
host cell membrane. Further, entry inhibitors cannot be administered through the oral
route, they need to be injected intravenously to prevent them from getting digested.
More than one anti-retroviral drug needs to be taken at a time for the therapy to be
effective over a long duration. This type of therapy is commonly referred to as combinational
therapy. The low replication fidelity of RT enzyme often causes it to make errors during viral
replication. As a result, several divergent strains of the virus are harbored within the patient.
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During anti-retroviral treatment, occasionally, a strain could emerge which is resistant to a
particular drug. This usually results in failure of the treatment, especially if the patient is not
on any other drug. Highly Active Antiretroviral Therapy or HAART is a highly effective
combination therapy where three or more anti-retroviral drugs, usually with a protease
inhibitor are given to battle drug-resistant mutants [9]. Twenty seven vaccine and fifteen
microbicide candidates were currently undergoing human trials worldwide at the beginning
of the year 2006. Several others are in experimental stages. Only one candidate vaccine,
called ALVAC (a canarypox-based vaccine) in combination with an AIDSVAX (a bivalent,
recombinant gp-120 based vaccine) booster is currently undergoing phase III trials in
Thailand involving nearly 16,000 volunteers. Results from this trial are expected by the year
2010. Four microbicide candidates have also reached phase III trials. These include SAVVY
(a surfactant), PRO2000, Carragaurd and cellulose sulfate (adsorption inhibitors). Vaccines
employing live-attenuated and whole-killed viruses are currently not undergoing human trials
because there is a slight risk that preparations could contain some active virus. Vaccine
designs that involve peptide epitopes of the virus and recombinant viral proteins present
more hope. Vaccines that employ a combination of designs and/or antigens and those that use
bacterial and viral vectors are also promising. The quest for an effective vaccine could go on
for several more decades, and it is highly unlikely that an effective one would be engineered
even by 2015. However, things look brighter in terms of microbicides and researchers
believe that an effective one could be made available by 2012, if sufficient funding and effort
is put in [10].
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1.5 HIV-1 morphology and genome organization
Mature HIV virions are roughly 80-120 nm in size, spherical particles with many spikes
projecting from the outer membrane. A characteristic bullet-shaped core is seen in the center
of the virion which encapsidates the genomic RNAs, other RNAs and many viral proteins.
Early studies revealed that retroviral particles are roughly composed of about 65% protein,
35% lipids and 1-2% RNA respectively. Genomic RNAs account for nearly two-thirds of the
viral RNA, while transfer RNAs, other small RNAs and some host RNAs add up to the
remaining one-third of the RNA content. In pure viral preparations, nearly three-quarters of
the total protein content are composed of Gag structural proteins, followed by the viral
envelope glycoproteins, viral enzyme proteins and some host cellular proteins. The HIV
genome is roughly 9 kb in size. Retroviruses are diploid with a genome comprised of two
positive sense single stranded RNAs that are identical/almost identical to each other. Bender
et al. extracted RNAs from many retroviral particles and examined them under denaturing
conditions. Electron microscopy revealed that they are non-covalently linked at many
regions, the strongest being the 5’ends. This occurs through complementarity between many
base pairs at the 5’ends. This region is called the Dimer Linkage Site (DLS) and has been
demonstrated to be a hot-spot for retroviral recombination in HIV and MuLV (Moloney
murine Leukemia Virus). Hence, the genomic RNA is said to be dimeric in nature. This
dimeric nature of the genome is primarily responsible for the high rate of recombination in
HIV, since sequences from both the RNAs could be copied into proviral DNA during reverse
transcription. Although virions contain two genome copies, only a single dsDNA is
produced. The presence of a second genomic RNA may act as a salvage pathway during
reverse transcription when broken or damaged regions in one of the RNAs are encountered
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reverse transcription can switch to the second. Two genomes also allow for extensive
recombination and therefore greatly contribute to genetic diversity [1].
Figure 1-2 shows the organization of the HIV genomic RNA. It is approximately 9,200
nucleotides in length. The viral RNA shares many similarities to an mRNA. There is a 5’-5’
linkage between the first encoded nucleotide of the genomic RNA and a methylated GDP
residue which serves as a cap at the 5’end. Following the methylated capped 5’end is the R
(Repeat) region. The U5 (Unique sequence at the 5’end) region and the PBS (Primer Binding
Site) sequences are present after this. This is followed by the ORFs (Open Reading Frame) of
the nine genes of HIV. These nine genes code for nine different proteins. Following this are
the PPT (polypurine tract), U3 (Unique sequence at 3’ end) and R regions. The 3’ end of the
genome is polyadenylated. It bears a poly (A) tail composed of nearly 50-200 non-coding A
residues. The virus makes a complete dsDNA copy of the RNA genome. This DNA is
referred to as the proviral DNA after it inserts in the host genome. A schematic of the
proviral DNA is also shown in Fig. 1-2. It can be noted that the proviral DNA contains two
LTR regions at both ends of the genome. These regions are called Long Terminal Repeats
and are found only in the proviral DNA. They are made as a result of duplication of the U5
and U3 regions during reverse transcription. LTRs are very vital for the obligatory second
strand transfer event that occurs during reverse transcription to complete proviral DNA
synthesis. Further, they also contain the promoter sequence which is mandatory for the
transcription event mediated by the host RNA polymerase II enzyme. The 3’ LTRs contain
some polyadenylation sites which are important for transcription as well [1]. Table 1-1 list
the nine genes of HIV and summarizes their function in the viral life cycle.
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Figure 1-1: Schematic of mature HIV-1 virion
Shown above is a schematic diagram of a mature HIV-1 virion. The viral RNA genome
consisting of two single-stranded, positive sense RNA strands coated with the nucleocapsid
proteins are shown. The viral capsid which encloses the genome is shown in blue. The capsid
also encloses the viral enzymes namely reverse transcriptase (RT), integrase (IN) and
accessory proteins namely vpr, nef and vif. The capsid made up of capsid protein (CA) is
surrounded by the matrix (MA). The viral protease enzyme (PR) is found within the matrix.
The matrix is enclosed within the viral envelope. The envelope glycoproteins namely gp120
(SU-surface unit) and gp41 (TM-transmembrane protein) are also shown. Figure obtained
from “AIDS Fact sheets and Brochures – How HIV Causes AIDS” maintained by National
Institute of Allergy and Infectious Diseases
(http://www.niaid.nih.gov/factsheets/howhiv.htm).
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Figure 1-2: HIV-1 RNA genome and proviral DNA
Shown above are the viral RNA genome and proviral DNA. The RNA genome contains a
methylated GDP cap at the 5’end. This is followed by the R (repeat), U5 (unique region at
5’end) and PBS (primer binding site) regions. The t-RNA primer binds to the PBS to initiate
reverse transcription. This is followed by the gag, pol and env coding regions. The PPT, U3
and R regions are found after the coding regions. PPT is the polypurine tract which acts as a
primer for plus sense strong stop DNA (+sssDNA) synthesis. U3 and R regions, respectively,
are unique and repeat regions at the 3’end. The HIV proviral DNA is also shown. The nine
genes of HIV-1 and their respective locations are also depicted. In some cases (Tat and Rev)
the proteins are produced from non-contiguous regions of RNA that are spliced together.
Note the presence of LTR (long terminal repeats) regions on either ends of the genome.
LTRs are very crucial in order to complete second transfer step during reverse transcription.
Figure obtained from “HIV/AIDS Resources on the Internet” maintained by The University
of Zambia, School of Medicine (http://www.medguide.org.zm/aids/HIVgenom.gif).
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p13/19 splicing of viral RNA,
nuclear export of RNA
vpr (viral protein R) p15 CD4 degradation, enhances
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with T cell signal transduction




p23 enhances virion infectivity
nef (negative
regulatory factor)
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interferes with activation of
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1.6 Viral life cycle
1.6.1 Attachment and entry: The HIV virion interacts with the host cell membrane by
means of the globular surface glycoprotein (SU) gp120. The CD4 antigen present on the
surface of phagocytic cells like macrophages, monocytes, helper-T cells and others serves as
the primary receptor for recognition by gp120. In addition to CD4, the virus needs another
co-receptor for attachment and entry. This co-receptor is of two kinds namely CXCR4 and
CCR5. FUSIN or CXCR4 is an α-chemokine receptor found on T-cells. Hence the syncitia
inducing (SI) strains of HIV-1 which use the FUSIN co-receptor for entry are named T-
tropic. Whereas the non-syncitia inducing (NSI) strains of the virus that use the CCR5 (a β-
chemokine receptor) receptor found on macrophages are named M-tropic. Viral strains that
use only the CCR5 co-receptor for attachment are called R5 while those that use only the
CXCR4 co-receptor are termed X4. This interaction exposes the V3 loop of gp120. The
conformational change in gp120 exposes a fusion peptide in gp41, thereby enabling it to
mediate fusion with the host cell envelope. Once the viral envelope fuses, the capsid
containing the genome and other viral proteins is released into the cytoplasm [11].
1.6.2 Viral replication: Viral replication occurs within the ribonucleoprotein complex
which encloses RNA, RT, NC and other viral proteins. The activity of RT was extensively
studied by Howard Temin and David Baltimore by monitoring replication intermediates in
purified virions. In 1970 their independent discoveries of an RNA-dependant DNA
polymerase or reverse transcriptase was reported and these scientists later shared a Nobel
Prize for the discovery. Reverse transcriptase (RT) is a multi-functional enzyme that
possesses RNA-dependant DNA polymerase activity, DNA-dependant DNA polymerase
activity and RNase H activity. The retroviral nucleocapsid protein (NC) also has a multitude
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of functions during viral replication. The virus generates a complete dsDNA copy of its RNA
genome by reverse transcription. Figure 1-3 [12] shows a schematic diagram of the process
of reverse transcription. The viral genomic RNA is denoted in black; minus-strand and plus-
strand DNAs are denoted in orange and red respectively. The following are the various steps
that occur during reverse transcription:
1. The partially unwound t-RNA primer is annealed to the PBS at the 5’end of the
RNA genome by means of an 18 base complimentary region. RT initiates minus strand
DNA synthesis using the 3’end of this t-RNA primer. Synthesis proceeds till the 5’end of
the RNA is reached generating a short DNA intermediate termed –sss DNA (minus-
strand strong stop DNA).
2. RNase H activity of RT degrades the RNA from the RNA/-sss DNA hybrid. The
complementarity in the R regions between the 3’ends of –sss DNA and viral RNA allows
the first strand transfer/jump of the –sss DNA to the 3’end of the RNA.
3. Extension of the minus strand DNA resumes and continues to the PBS region at
the 5’end of the RNA genome. This is accompanied by RT mediated RNase H
degradation of the template RNA.
4. PPT or polypurine tract remains resistant to the RNase H degradation of RT and
serves as the primer for +sss (plus-strand strong stop) DNA synthesis. Plus-strand DNA
synthesis proceeds till the PBS region on the t-RNA is reached. A modified base at the
19th position from 3’ end of the tRNA results in termination of synthesis after the first 18
bases are copied. Subsequently, RT degrades the t-RNA primer and the PPT region.
5. The complementarity between PBS regions of the minus-strand DNA and the +sss
DNA mediates the second transfer event.
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6. The minus-strand DNA/+sss DNA duplex then circularizes in order to serve as
templates for one another.
7. Synthesis of minus-strand and plus-strand DNA is then completed, thereby
generating a complete blunt-ended DNA copy of the viral RNA genome. Duplication of
the U5 and U3 sequences generates the LTRs (long terminal repeats) on either ends of the
proviral DNA [12].
1.6.3 Integration, assembly and release: The viral DNA then integrates randomly into
the host chromosomal DNA as part of a pre-integration complex. Although integration is
random and non-uniform, highly bent regions such as nucleosomes are preferred target sites.
The integrated DNA is referred to as the provirus. The virus then uses host cell machinery to
generate viral RNA and proteins. Assembly of viral RNA and proteins then begins near the
plasma membrane of the host cell (See Fig. 1-4). HIV packages two RNA genomes along
with viral proteins and host tRNAs into each virion. The viral glycoproteins then associate
with the inner surface of the host cell’s plasma membrane and begin to bud from the cell. The
virion is immature initially. Maturation occurs either in the budding virion or after budding is
completed. Maturation is brought about by viral protease enzymes that cleave precursor
polyproteins into functional peptides and enzymes. This results in the formation of a mature
HIV virion capable of infecting other cells [13], [14], [15].
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Figure 1-3: Schematic of Reverse transcription: Shown is the schematic model of reverse
transcription illustrating the various events described above.
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Figure 1-4: Viral life cycle
Shown above is a schematic diagram illustrating the various events occurring during the HIV
viral life cycle. The virus first attaches to the host cell by means its surface glycoprotein
gp120. It then fuses with the host cell membrane and releases a nucleoprotein complex into
the cytoplasm. A complete dsDNA copy of the viral genome is made via reverse
transcription. The dsDNA then randomly integrates into the host chromosomal DNA as a
provirus. Synthesis of viral RNA and proteins occurs using the host cell machinery. These
components then assemble near the host cell membrane where packaging occurs. The viral
glycoproteins then fuse with the host cell membrane and immature virions bud off. Viral
proteases complete maturation through proteolytic cleavage. Figure obtained from “AIDS
Fact sheets and Brochures – How HIV Causes AIDS” maintained by National Institute of
Allergy and Infectious Diseases (http://www.niaid.nih.gov/factsheets/howhiv.htm).
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1.7 Reverse transcriptase
The characteristic feature that distinguishes retroviruses from other viruses is the
conversion of their RNA genome into a DNA intermediate which integrates into the host
genome. The enzyme that brings about this “retro” or reverse flow of genetic information
contrary to the central dogma of genetics is reverse transcriptase (RT). HIV RT was
independently discovered by Howard Temin and David Baltimore in the year 1970 and was
heralded as one of the most significant contributions to the field of retrovirology. RT
possesses three independent activities namely: RNA-dependant DNA polymerase, DNA-
dependant DNA polymerase and RNase H activity. HIV-RT is active as a heterodimeric
protein consisting of two subunits with similar amino termini. The larger subunit is called
p66 and the smaller one is called p51. The suffix denotes their molecular weight in kDa. The
p66 subunit is 560 amino acids in length. The p51 subunit is produced as a result of
proteolytic cleavage from the carboxyl terminus of p66. Hence, it consists of the first 440
amino acids of p66. The p66 subunit folds into two domains, the polymerase and RNase H
domain. Since the p51 subunit corresponds to the first 440 amino acids of p66, it contains
only the polymerase domain and lacks the RNase H domain (from the carboxyl terminus)
[16]. The exact role of p51 is still not completely clear. Experiments carried out with HIV-1
specific inhibitors and certain thymidine triphosphate templates suggest that the polymerase
activity lies exclusively within the p66 subunit. Hostomsky et al. have shown that mutations
disrupting the polymerase active site in the p66/p51 heterodimer of RT can be tolerated by
p51 but not by p66. Le Grice et al. have conducted mutational studies in which the p51
subunit was inactivated by mutations and found that all the activities of RT were carried out
by the p66 subunit. This suggests that p51 is not directly involved in the polymerase and
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RNase H activities of RT [17]. Figure 1-5 shows a color-coded schematic ribbon diagram of
RT. RT folds into the characteristic open right handed conformation similar to many other
prokaryotic and eukaryotic DNA polymerases. The three domains namely fingers, palm and
thumb that give it the shape of an open right hand are shown in blue, red and green
respectively. The connection domain between the two subunits is shown in yellow. The
active site of the enzyme is found in the palm domain. The template is held in the groove of
the hand. The thumb touches the minor groove of the template. The fingers enclose the
primer portion of the primer-template hybrid. Larder et al. have shown through site-directed
mutagenesis that the polymerase domain active site contains three aspartic acid residues:
Asp110, Asp185 and Asp186 [18]. This lies in the N-terminal domain as shown in the linear
schematic diagram in Fig 1-6. The RNase H domain lies in the C-terminus and is shown in
gold. The four active site residues of this domain are Asp443, Glu478, Asp498 and Asp549
[19], [20]. Studies have shown that the distance between these two active sites is around
18/19 nucleotides. This is represented linearly as well (See Fig 1-6) [21]. The highly
negatively charged catalytic core formed due to the active site amino acids enables RT to
coordinate Mg2+. Processivity of an enzyme refers to the average number of nucleotides that
it incorporates into the growing nascent strand in a single binding event. HIV-1 RT’s
processivity is approximately 100 which is low for a replicative polymerase. It does not
possess a 3’ to 5’ proofreading/exonuclease activity. Further, it also has low fidelity with an
estimated error rate of 10-4 to 10-5 per base incorporated. The low fidelity coupled with a high
recombination rate is a major driving force for generating genetic diversity that is prevalent
with HIV [22], [23].
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Figure 1-5: HIV-1 RT
Shown is a schematic ribbon diagram of HIV-1 reverse transcriptase (RT) enzyme. It is a
heterodimeric enzyme that contains p51 and p66 subunits. The p66 subunit contains
polymerase and RNase H domains, while the p51 lacks the RNase H domain. The
polymerase domain bears the characteristic open right hand conformation with the fingers
(blue), palm (red) and thumb (green) domains. The connection domain linking the two
subunits is shown in yellow, while the RNase H domain is shown in gold. Figure obtained
from “Overview of RT Structure” maintained by HIV Drug Resistance Program, National
Cancer Institute (http://www.retrovirus.info/rt/overview_f1.html).
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Figure 1-6: Linear diagram of HIV-1 RT
Shown is a linear diagram representing the two RT subunits, p66 and p51. The p66 subunit
contains both polymerase and RNase H domains and is 560 amino acids in length. The
polymerase active site catalytic residues (Asp110, Asp185 and Asp186) are indicated. The
RNase H active site catalytic residues (Asp443, Glu478, Asp498 and Asp549) are also
shown. The p51 subunit which is produced as a result of proteolytic cleavage from the C-
terminal of p66 is shorter and lacks the RNase H domain. Hence it contains 440 amino acids.
The color coordination between the ribbon diagram shown previously (See Fig. 1-5) and the
linear representation is the same. Figure obtained from “Overview of RT Structure”
maintained by HIV Drug Resistance Program, National Cancer Institute
(http://www.retrovirus.info/rt/overview_f1.html).
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1.8 Recombination and genetic diversity in HIV
HIV and retroviruses in general possesses one of the highest recombinogenic potentials
among viruses. This is well documented by the huge number of recombinant genetic variants
that are found within HIV. As was noted earlier in section 1.1, there are several established
subtypes within the HIV-1 species. These most likely represent divergent evolution from a
common progenitor. In recent years co-infection of individual hosts with different subtypes
has resulted in new circulating recombinant forms (CRFs) that have become established in
various regions of the world. The CRFs contain genome regions derived from two or more
subtypes. The well established CRFs originate diverse recombinant virus forms that are also
found in many regions. The term intersubtype recombinant or ISR is used to refer to these
genetically diverse recombinants. For example, any recombinant containing genome regions
from an A and E virus is an A/E ISR while a specific A/E CRF such as CRF01_A/E is the
most prevalent virus infecting people in Thailand. The huge genetic diversity of HIV-1 has
caused the HIV population to be referred to as a quasispecies which is defined as a “dynamic
distribution of nonidentical but related viral replicons” [24].
HIV continually mutates and generates genetic variants. It circumvents drug therapy by
producing drug-resistant mutants. Several factors have been found to be responsible for the
huge genetic diversity of HIV. They are:
1. Low fidelity of RT enzyme and lack of 3’-5’ proofreading/exonuclease activity.
2. Recombination (This will be discussed in detail shortly).
3. Presence of diploid genome provides a greater chance for recombination during
reverse transcription.
23
4. Possible low fidelity of host RNA Pol II enzyme that is involved in the virus life
cycle.
5. High rate of viral replication: As many as 1010 new virions are produced per day
in an infected individual. This increases the potential for a large number of new mutant
strains.
Further, HIV also evades the immune response generated by the host by employing
several pathways. Some of them include:
1. Continual depletion of immune cells leading to progressive immune deficiency.
2. Cell to cell adhesion and syncytia formation causing infection to spread without a
virion being exposed to the blood stream and immune system.
3. Lack of viral proteins in the plasma membrane during macrophage infection
curtails immune stimulation and recognition.
4. Long term latency in some infected immune cells serving as a reservoir for future
infections.
Recombination is one of the main factors responsible for generating genetic diversity
within HIV. The diploid nature of the retroviral genome suggests that recombination may be
a crucial function necessary for the virus to replicate and evolve. HIV packages two RNAs
within each virion. The RNA genomes could be identical or almost identical. This would
likely be the case in cells infected by a single virus as the genomes would be derived from
one provirus. In these cases the fidelity of host RNA pol II would be the major source of
diversity. Although the exact fidelity of this enzyme is unknown, results suggest it has
considerably higher fidelity than RT [25]. Recombination between identical genomes would
not produce genetic diversity. In some cases cells may be infected by more than one virus
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and in these cases multiple proviruses can be made. Different genomes can become packaged
in the same virion in these cells and the impact of recombination is greater. For simple
retroviruses such as spleen necrosis virus (SNV) and MuLV, homologous recombination was
shown to occur in nearly 4% (the rate is much greater in HIV as noted below) of DNAs in
progeny virions during one replication cycle when genetic markers spanning 1 kb were used.
This corresponds to about a 40% chance of recombination per replication round for a 10,000
base genome. The rate of non-homologous recombination is significantly lower; only 1/100
to 1/1000 [26]. Recombination in HIV occurs through a process called strand transfer or
template switching (also called strand jumping). Strand transfer refers to the process by
which nascent DNA being synthesized on one RNA strand (referred as donor) falls off and
jumps onto homologous regions on either the same RNA or on another RNA strand (referred
as acceptor) where synthesis is completed. If the transfer occurs to the acceptor template, the
resultant DNA would be a chimera between the parent and acceptor RNA templates. As
described earlier in section 1.6.2, the process of viral replication requires two mandatory
strand transfer reactions (also called strong stop DNA transfers) in order to complete reverse
transcription. The first strand transfer occurs when the nascent –sss DNA (minus-strand
strong-stop DNA) jumps and anneals to the 3’end of genomic RNA. This is mediated
through complementarity between the R or repeat regions. The second strand jump occurs
when the nascent +sssDNA anneals to the complementary PBS region found in the minus-
strand DNA resulting in circularizing of the genome and completion of plus-strand DNA
synthesis. These strand transfer events occur at the end/termini of the genome. Hence, they
are termed as end/terminal strand transfers. Besides end strand transfer, the virus can also
undergo numerous internal strand transfers which occur randomly anywhere throughout the
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genome [27], [28]. These events can occur anytime during the minus/plus strand DNA
synthesis. Zhuang et al. have shown that the average rate of recombination in HIV is about
2.8 crossovers per cycle of viral replication [29]. Cell infection experiments conducted by
Levy et al. in T-lymphocytes showed a higher recombination rate of about 10 cross-overs per
replication cycle. Nearly thirty crossover events were reported to have occurred during
infection of macrophages. The latter figure represents approximately one recombination
event for every 350 nucleotides synthesized [30]. In one report it was demonstrated that HIV-
1 recombines ten to twenty times more frequently than MuLV. The reason for the difference
is unclear, although HIV is considered a “complex” retrovirus meaning it produces several
regulatory proteins (Tat and Rev) for example, while MuLV is a “simple” retrovirus. Virion
morphology is also quite different for these viruses [28].
Currently, there are two models that explain the mechanism of retroviral recombination:
copy choice and strand-displacement assimilation. The copy choice model explains strand
transfers that occur during minus-strand DNA synthesis. According to this model, the nascent
DNA switches from one RNA template to another during minus-strand synthesis. This model
is a modified version of the original “forced copy-choice” model which postulates that breaks
in the RNA genome force the nascent DNA to switch templates in order to complete
synthesis [31]. Subsequently it was shown that breaks were not required for strand transfer to
occur. Experimental evidence provided by Hu and Temin showed that while γ-radiation,
which induced genome breaks, reduced the recovery of viral RNA, it did not increase the
frequency of viral recombination [32]. Efficient recombination was reported in experiments
where unbroken RNA templates were used [33]. DeStefano et al. have shown that efficient
template switching occurs between internal regions of RNA templates [34]. In regions of
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unbroken RNA, other factors such as the presence of secondary structures could cause
stalling of RT, thereby inducing strand transfer. The strand-displacement assimilation model
explains strand transfers that occur during plus-strand DNA synthesis. This model was
proposed based on observations made on H-branched structures that are classified as
intermediates during recombination [35]. Though plus-strand synthesis is initiated
predominantly at the polypurine tract, several reports have demonstrated that in some
retroviruses, it could be initiated discontinuously throughout the genome at many points [36].
According to this model, at any given time, there are many nascent plus-strand DNA
fragments bound to the minus-strand DNA template. The 5’ends of these nascent plus-strand
DNAs tend to get displaced by the 3’ends of the preceding plus-strand DNAs. This results in
the displacement of such nascent plus-strand DNAs. These displaced fragments could either
base pair with the other minus-strand DNA template or randomly integrate themselves
between the remaining plus-strand DNA fragments bound to the parent minus-strand DNA
template. Either pathway would result in genetic recombination. It should be noted that this
model requires the presence of two minus-strand DNA copies of the homologous region
where recombination could potentially occur. Results indicate that majority of recombination
in retroviruses occurs during minus strand DNA synthesis, probably by copy choice.
1.9 Nucleocapsid protein
The nucleocapsid protein (NC) of HIV-1 is a small (55 amino acid) protein that coats the
genomic RNA in the mature virion. The presence of fifteen arginine and lysine residues
makes it highly basic. It has a net positive charge of +13 and a pI between 10.0 and 11.0.
Nearly 2000 molecules of NC are found within the virion core [37]. The gag gene of
retroviruses encodes the Gag precursor polyprotein. Retroviral internal structural proteins are
27
derived from Gag. It is involved in copackaging of two unspliced RNA genomes and hence
plays an important role in viral assembly. After assembly, the immature virion buds off.
Maturation could occur either at the time of budding or after budding. It involves cleavage of
precursor polyproteins by the viral enzyme protease to yield smaller functional proteins. NC
is produced as a result of this proteolytic cleavage [38], [39]. All known orthoretroviruses
(except spumaviruses) contain one or two -Cys-X2-Cys-X4-His-X4-Cys- (CCHC) zinc finger
motifs as part of NC. Figure 1-7 shows a schematic diagram of HIV-1 NC. In solution, HIV
NC contains two rigid fourteen residue CX2CX4HX4C (where X can be any amino acid)
motifs, where three cysteines and one histidine coordinate one zinc ion. The strong
coordination between the zinc ions and the fingers exists in virions and under in vitro
conditions as well. The presence of a cluster of arginine or lysine residues near CCHC motifs
is typical, and this is seen in NC as well. The two zinc fingers of NC are connected by a
highly basic seven amino acid linker (RAPRKKG) [37], [40], [41]. The proline residue found
in the linker has been shown to slightly bend the linker such that proximity between the two
fingers is increased [42]. Changes that affect zinc binding or deletion of zinc fingers are not
tolerated resulting in defective RNA packaging or absence of genomic RNA in virions. Thus,
zinc fingers are potential targets for anti-viral agents that eject zinc. The two zinc fingers of
NC are flanked by the N and C terminal tails. The tails have been shown to be highly flexible
and possess no predicted structure by NMR [42]. However circular-dichroism studies have
predicted that N and C terminal regions could form helices and that there is clustering of the
N-terminal basic amino acid residues on one side of the predicted helix [43]. The 120 nt
(nucleotide) long viral packaging signal called the ψ site is found at the 5’end of unspliced
RNAs. NMR studies have revealed interactions between NC and four RNA stem loops (SL1-
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SL4) that constitute the ψ packaging signal. These interactions are crucial for viral assembly
and packaging. More specifically, the following interactions were found between NC and
SL3. The lysine (Lys3) and arginine (Arg10) residues at the N-terminal zinc finger form a 310
helix. This helix binds with the major groove of SL3. There is a hydrophobic pocket within
finger one which is formed of Val13, Phe16, Ile24 and Ala25. Hydrogen bonding occurs
between the guanosine residues of the RNA and amide atoms of Phe16 and Ala25. Another
hydrophobic cleft consisting of Trp37, Gln45 and Met46 is found in finger two. This is
formed due to hydrophobic interactions between the side chains of these residues.
Electrostatic interactions are found between Arg32 and negatively charged phosphodiester
backbone of the RNA. There are few differences between NC interactions with SL2 and SL3.
The 310 helix binds to the minor groove of SL2 and predominantly, electrostatic interactions
occur between NC and SL2 [44].
29
Figure 1-7: Schematic of HIV-1 pNL4-3 nucleocapsid protein
Shown is a schematic diagram of HIV-1 nucleocapsid protein (NC). It is 55 amino acids in
length and contains 15 arginine and lysine residues. NC contains two CCHC zinc fingers
motifs. The fingers are numbered from the NH2 terminus and are termed as F1 and F2. The
three cysteines and one histidine residue in each finger serve to coordinate one zinc ion. The
amino acid differences between the two fingers are indicated in red.
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NC is a multifunctional protein and contributes significantly to several important steps in
the viral replication cycle [37], [45], [46], [47], [48]. Thus, NC is a potential target for NC-
inhibitor drugs [49], [50], [51] and vaccine development [52]. NC coats the viral RNA,
though not completely at saturating levels, thereby protecting it from nucleases [53].
Although NC binds to both RNA and DNA, it exhibits preferential binding to single-stranded
nucleic acids. NC has been shown to bind to RNA in the following order of preference:
retroviral RNA > mRNA > rRNA > poly r(A) [37], [54]. NC is involved in several steps
during viral replication. Reverse transcription is initiated by the host t-RNALys,3 primer that
remains bound to the PBS region of the viral genome. NC enhances the unwinding of the t-
RNA primer [47], [55] and stimulates its annealing to the PBS [56], [57], [58]. Similar
properties were also observed in in-vitro experiments conducted with MuLV NC mutants,
where basic residues of this NC were shown to enhance t-RNA annealing [59], [60]. NC has
been shown to modestly enhance the processivity of RT during reverse transcription [61],
[62], [63]. In vitro studies have revealed that NC stimulates and modulates the RNase H
activity of RT [64], [65]. NC has been shown to stimulate both minus and plus-strand strong-
stop DNA transfers and viral recombination in general [66], [67], [68], [69], [70], [71], [72].
More specifically, the levels of transfer efficiency in the first strand transfer event increase
by nearly 60% upon addition of NC [41]. Wu et al. have monitored plus-strand strong-stop
DNA transfer in detail both in endogenous and reconstituted systems. They have
demonstrated that NC facilitates removal of the t-RNA primer to complete annealing of PBS
sequences during the second strand transfer reaction [73]. In particular, Guo et al. have
shown that the invariant zinc fingers of NC are important for complete t-RNA removal [46].
Results
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Figure 1-8: HIV-1 NC-SL3 ψ RNA complex
Shown is the ribbon diagram of HIV-1 NC SL3 ψ complex. The color coding is as follows:
RNA-gray; first zinc finger-turquoise; linker-yellow; second zinc finger-green; zinc atoms-
white spheres; 310 helix-blue; Colored nucleobases in RNA: A
8-blue, G9-dark orange, G7-
violet, G6-light green. Figure obtained from De Guzman et al [44].
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from many reports indicate that NC also reduces RT pausing and promotes internal strand
transfers throughout the genome [45], [63], [67], [71]. Studies show that NC is possibly
involved in the integration and protection of the newly synthesized viral genome [74], [75],
[53], [76]. As described previously, specific interactions between the NC part of the Gag
precursor polyprotein and the ψ packaging signal have been observed [77]. Thus, NC is also
involved in recognition and packaging of the genome [78], [79], [80], [81]. Upon budding
from the host cell, the virion is immature. The two almost identical RNA genomes are held
together loosely by weak interactions at the 5’ends. During maturation, the RNA dimer
undergoes conformational changes which enable it to become more compact and
thermodynamically stable. NC has been shown to enhance the formation of a dimer which
has the maximum number of base pairs. This enables the genome to overcome the
unfavorable loop-loop dimer conformation and assume a more compact and stable form [82].
NC has been shown to play a role in genomic maturation by promoting dimerization between
the two RNAs [83], [84], [85]. Thus, it can be clearly seen that NC is involved in several
steps of the viral replication cycle.
NC is a classic example of a nucleic acid chaperone protein [37], [41]. Chaperones are
proteins that help nucleic acids to attain the optimal thermodynamically stable conformation.
These proteins transiently break base pairs in nucleic acids thereby unfolding them.
Subsequently they catalyze the re-pairing or annealing of free bases into an optimal
conformation that has the maximum number of base pairs. This enables nucleic acids to
overcome suboptimal conformations and unfavorable kinetic traps [86].
One report has demonstrated that NC inhibits annealing of very short, unstructured,
complementary sequences [87]. NC presumably accelerates annealing of non-structured
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complements provided that they are long enough to form a stable hybrid capable of
overcoming NC's helix-destabilizing activity. The observed inhibition could be due to short
regions of complementarity. This is further supported by results showing that NC can also
inhibit binding of longer complementary regions when non-complementary bases that
weaken the hybrid are inserted along the region [88]. Several reports demonstrate that NC
enhances annealing even on non-retroviral nucleic acid templates [89], [63], [90]. Thus, the
chaperone activity of NC has been well documented by several studies conducted on
different types of nucleic acids.
The biochemical activity of NC is critical for all of its functions. Several studies have
been conducted to gain knowledge in this area. Work done in this thesis sheds light onto two
very important aspects of NC’s nucleic acid chaperone activity; namely helix-
destabilization/unwinding and aggregation/annealing. The former is essentially due to NC’s
ability to weaken Watson-Crick base-pairing in helical structures while the latter effectively
concentrates nucleic acids by causing them to aggregate. Previous work in this lab and others
demonstrated that the N-terminal zinc finger (finger 1) of NC is pivotal for helix-
destabilizing while the second finger seems to play a lesser role in this activity [91]. The
basic approach used in this thesis was to make mutations in finger 1 in an attempt to
understand which of the amino acid difference between the two fingers is responsible for
their functional differences. A detailed understanding of how NC functions at an amino acid
level could potentially help us to uncover ways to target this protein. This could aid in
designing molecules that bind tightly to NC and prevent it from interacting with nucleic
acids.
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Chapter 2 Evaluation of the chaperone activity of HIV-1 nucleocapsid
protein at an amino acid level
2.1 Introduction
HIV-1 NC acts as a nucleic acid chaperone. As discussed earlier in Section 1.9, NC’s
chaperone activity participates in a multitude of functions that it executes throughout viral
replication. Upon binding to nucleic acids, it can transiently break base pairs. This enables
kinetically trapped nucleic acids to overcome suboptimal conformations. The free bases are
now available for re-pairing. NC then catalyzes their rearrangement into optimal
conformations with the higher thermodynamic stability. However, the exact mechanism by
which this activity is initiated is still not well understood. Such nucleic acid chaperone
proteins are also found in prokaryotes and eukaryotes. For e.g., E.coli SSB (single-stranded
binding protein) has been shown to unwind secondary structures and neutralize negative
charges on the phosphate backbone of nucleic acids, thereby catalyzing annealing of
complementary DNA strands [92]. Pontius et al. have shown that the human A1 hnRNP
protein enhances strand exchange and annealing between nucleic acid complements [93].
Williams et al. have conducted in depth studies in gp32 (gene 32 protein) found in T4
bacteriophages. Destabilization of duplexes by gp32 and specific binding to single-stranded
DNA is vital for phage replication, recombination and repair. However, unlike E.coli SSB
and T4 gp32 which can bring about complete helix destabilization, HIV-1 NC is relatively a
much weaker duplex destabilizer [94]. Thus far, approximately 50 different proteins from
virus, eukaryotes, and prokaryotes have been identified as potential nucleic acid chaperone
proteins (For a list see: http://mendel.imp.ac.at/home/Birgit.Eisenhaber/RNA-
chaperones/list.html).
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Many attempts have been made to further investigate the role of specific regions in NC
responsible for its chaperone activity. Both the flexible backbone and rigid finger regions of
NC are of prime importance. However, experiments conducted with finger deletion mutants
demonstrate that zinc finger architecture does not appear to be significant for enhancing
tRNA annealing and genomic RNA dimerization. In vitro tRNA annealing experiments were
conducted using NC mutants where the three cysteines residues were replaced by serines
(SSHS NC). Results showed that SSHS NC was comparable to wt NC [47]. However, recent
studies indicate that this may result from the mutual cancellation of two factors: SSHS NC is
less effective than wt NC as a duplex destabilizer, but more effective as a duplex nucleating
agent due to increased flexibility [95]. In vitro assays conducted by Heath et al. have shown
that NC finger mutants with little apparent unwinding activity can also stimulate the
hybridization of non-structured nucleic acid complements, presumably because wt NC’s
aggregation effect is not lost [91]. In contrast, results also indicate that the fingers are
important for viral packaging [96], [97], minus-strand strong-stop transfer and recombination
in general [46], [98]. Cellular infections with NC mutants demonstrated the pivotal role of
both fingers in dimer formation and general viability [99]. The unwinding ability of NC also
requires zinc fingers, in particular finger one [91]. Studies conducted with mutant NC
proteins indicate that 1.1 NC (a mutant NC that has two copies of finger one) and SSHS NC
(with an inactivated finger two) retain unwinding activity. In contrast, 2.2 NC (a mutant NC
that has two copies of finger two) and SSHS NC (with an inactivated finger one) have little
unwinding activity [91]. A finger switch mutant termed 2.1 (where positions of the two
fingers are interchanged) also retained partial unwinding activity suggesting that both context
and amino acid composition play important roles [91]. Further, truncated NC proteins lacking
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the first 12 N-terminal non-finger amino acids (NC 12-55) showed no reduction in helix-
destabilizing activity. Single molecule stretching experiments conducted with NC mutants
have shown that finger one is crucial for helix destabilization and enhancement of helix to
coil DNA transitions [100]. Experiments that measured binding of complementary DNA to
the highly structured HIV-1 TAR region (an assay that mimics the first strand transfer event
with –sssDNA transferring to the 3’ R region) revealed that finger one is vital for optimum
annealing. Mutations in finger two did not affect NC’s annealing ability to a great extent.
Guo et al. have demonstrated using NC finger mutants that both context and amino acid
content of fingers are critical for both minus and plus-strand transfer reactions. Thus, NC’s
chaperone activity has been extensively studied and well documented [98].
A clearer understanding of NC’s chaperone activity in viral replication would require in
depth knowledge of NC’s nucleic acid binding properties. Within the mature virion, NC is
tightly associated with the genomic RNA. Although it binds to both RNA and DNA, it
exhibits preferential binding towards single ss RNA over ss DNA. However, binding affinity
of NC to both ss and ds DNA has shown to be similar by fluorescence experiments [101].
Further, it exhibits both general and sequence specific nucleic acid binding properties
which are complex and ionic-strength dependant. Surface plasmon resonance experiments
have shown that NC binds preferentially to TG repeats in DNA. This was observed with UG
regions as well when tested with RNA [102], [103], [104]. Further, NC demonstrates
preferential binding towards GNG sequences in single-stranded loop regions [77], [44].
Results indicate that NC exhibits non-specific binding towards t-RNA primers. This is in
consensus with the fact that NC does not play a role in t-RNA primer selection [105]. The
intrinsic fluorescence of NC’s Trp-37 residue and CD-spectral studies has given useful
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insights into its binding site sizes [90]. Early studies that monitored NC71 binding to poly(A)
have shown the apparent binding site size (napp) to be different under varying protein:nt
ratios. The n value was found to be 14 and 8 under low and high ratios respectively.
However, upon deletion of 14 residues from the COOH terminus to produce the mature
NC55, this variant behavior was resolved and a consistent napp value in the range of 6-7 was
obtained. The general consensus is that mature NC’s binding site is between 5-8 nucleotides
[38], [102], [90], [105], [106], [54], [107], [108].
The ability of NC to bind stochiometrically to varied nucleic acid structures stems from
the high flexibility of its backbone. This has been demonstrated through biophysical
experiments by several groups [109], [110], [111], [112], [113], [114]. The large number of
polyelectrolyte interactions between NC and the phosphate backbone of nucleic acids
supports the hypothesis that the binding event mediated by NC is significantly driven by a
large efflux of cations (For e.g.: Na+ ions). This is clearly demonstrated by NC’s salt-
dependant duplex stabilizing effect [102], [115], [105], [108], [116]. NC bears close
resemblance to several cationic ligands like polyamines, polyLysine, cobalt hexamine3+ and
Mg2+/ Ca2+ in these aspects. These ligands are highly mobile in nature, bind nucleic acids
non-specifically and bring about nucleic acid aggregation similar to NC [117], [118], [119].
A wealth of information about nucleic acid binding properties of NC has been obtained
by studying binding interactions between NC and the ψ packaging signal located at 5’end of
the viral genome. The ψ site is 120 nucleotides long and contains sequences essential for
viral packaging during assembly. Four stem loops namely SL1, SL2, SL3 and SL4 have been
proposed to be formed by these nucleotides. Several groups have extensively studied the
binding of NC to these stem loops. However, there were significant differences in Kd values
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determined. This seemed to depend on the type of NC used, buffer conditions and techniques
used for analysis. Kd values of 100-320 nM were observed with SL1 and SL4 indicating
weaker binding. The highest binding affinity was reported with SL2 and SL3 with Kd values
ranging between 20-30 nM [116]. Assays done with DNA analogues of RNA stem loops
revealed that NC binds less tightly to the former [115], [120], [121], [122]. Computational
studies have also shown that the maximum contribution towards binding energy in both
complexes is from electrostatic interactions between NC-stem loop complexes. Further,
while Lys26 residue of NC seems to be very significant for electrostatic binding to SL2,
basic residues in the N-terminal helix and finger one seem to be important for electrostatic
interactions with SL3 [123]. As mentioned earlier in Sec 1-9, in the NC-SL3 complex, the
lysine (Lys3) and arginine (Arg10) residues at the N-terminal zinc finger form a 310 helix.
This helix is well packed against the first zinc finger and hence is able to penetrate into the
major groove of SL3. However, interactions between SL2 and the 310 helix occur at an A-U-
A base triple region in SL2’s minor groove [77], [44], [124]. There are lots of similarities
between NC interactions with SL2 and SL3. In both cases, intramolecular salt bridges are
formed by basic residues which minimize electrostatic repulsions. Further, NC’s zinc fingers
show preferential binding towards ss loop regions, while the highly positively charged N-
terminus binds to the ds stem of the RNA hairpin [77], [44]. Steady-state and time resolved
fluorescence studies have also shown that the interaction between Trp37 and guanosine
residues depends on its location in the C-terminal zinc finger and correct folding of the
finger. While Phe16 contributed vastly to the binding energy, Trp61’s (in NC71) contribution
was minimal. Further, electrostatic interactions between the N and C terminii of NC and SL3
were stabilized by the stem loop structure of SL3 (See Fig. 1-8). Also, Vuilleumier et al.
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point out that strong binding affinities are not observed during selective binding by NC since
it probably recognizes nucleic acids via a small number of sites [115]. Lastly, while
nitrocellulose filter binding assays show that NC binds tightly to SL4, gel assays and NMR
studies demonstrate otherwise [125], [126].
As described earlier in Sec 1-8, minus-strand transfer generates a minus DNA copy of
the RNA genome. Earlier, minus strand transfer was thought to be an intermolecular reaction
(occurs on the other genomic RNA) [127]. However, subsequently it was also shown to be
intramolecular (transfer occurs on the same genomic RNA template) [128], [129]. As
described earlier in Sec 1-9, several groups have demonstrated using in vitro assays that
HIV-1 NC enhances the rate of minus-strand several fold. HIV-1 NC has been shown to
enhance minus strand transfer by facilitating annealing of the R regions and accelerates this
step by nearly 3000 fold [72]. The R region contains the highly structured TAR element.
Hence, this reaction is most likely brought about by the helix-destabilizing activity of NC
[46], [98], [72], [87], [100], [130], [91]. NC mediated unwinding of secondary structures in
the R region is thought to be the rate limiting step in this reaction [72]. NC also plays another
important role during minus-strand transfer. It inhibits self-priming at the 3’end of –sssDNA.
This is a dead-end, non-specific reaction resulting in the formation of TAR-induced fold-
back structures that competes with the minus-strand transfer step. Several investigators have
conducted in-depth studies in this area. There are conflicting reports on the effect of NC on
inhibition of self-priming in the absence of acceptor RNA. However, there is a general
consensus that self-priming is greatly reduced when both acceptor RNA and NC are present,
resulting in increased rate of strand transfer [131], [68], [46], [98], [132]. This demonstrates a
typical case of NC’s chaperone activity. Here, the hybrid between –sssDNA and the acceptor
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RNA is more stable than self-primed products or either reactant [133]. Biophysical
experiments have given useful insights into NC mediated inhibition of self-priming. FRET
assays showed that in the presence of acceptor RNA, most TAR DNA hairpins were
unfolded. While, in the absence of complementary RNA, although NC enhanced fraying of
TAR DNA ends is observed, it was unable to fully unwind the hairpins. This clearly explains
why NC is unable to inhibit self-priming under such conditions [134].
Annealing of complementary PBS segments at the 3’ends of minus DNA and +sssDNA
constitutes the second strand transfer step. NC plays two important roles during plus-strand
transfer. It facilitates removal of the t-RNA primer from minus DNA and stimulates
annealing between minus DNA and +sssDNA. NC enhanced plus-strand transfer is another
clear manifestation of its nucleic acid chaperone activity. A parallel situation is seen during
NC catalyzed minus-strand transfer when it mediates removal of 5’donor RNA fragments
from –sssDNA, thereby favoring formation of a more stable RNA-DNA hybrid [82].
However, in addition to these two terminal/end strand transfer events, the viral genome
also undergoes transfers internally along the entire genome. They have been shown to occur
at a greater frequency during minus DNA synthesis. Internal strand transfers during minus
strand synthesis are believed to occur due to several reasons include a break/damage in the
genome and secondary structures/specific sequences that hamper the progress of RT along
the genome. Such regions are termed pause sites. Refer to Section 1.8 of this thesis for a
detailed discussion on internal strand transfer.
Previous results from our lab and others (as discussed above) have shown that the first
zinc finger of NC is primarily responsible for its helix destabilizing activity whereas the
second finger plays an accessory role by enhancing annealing further [91]. It is not clear what
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causes this discrepancy between the activities of the two fingers. There are five amino acid
differences between the two zinc fingers of NC in HIV-1 clone pNL4-3. These include
(finger one to finger two): phenylalanine to tryptophan (F to W), asparagine to lysine (N to
K), isoleucine to glutamine (I to Q), alanine to methionine (A to M), and asparagine to
aspartic acid (N to D) at positions 16, 17, 24, 25, and 27 of finger one, respectively (See Fig.
1-7). We wished to determine at an amino acid level the reason for the apparent distinction
between the two fingers. Work presented in this thesis evaluates the helix destabilizing
activity of NC by analyzing NC mutants in unwinding and annealing assays with structured
and unstructured substrates. Nitrocellulose filter binding assays were performed to see if the
mutations affect binding to nucleic acids as this may play a role in unwinding activity.
Further, this would also give us additional insight into binding affinities of amino acid
residues vital for NC’s helix-destabilization function. We have also developed in vitro
systems using purified proteins and virus-derived nucleic acids substrates to model and test
internal strand transfer events. Previous results have shown that NC activity is more
important for allowing transfer on structured substrates such as the gag-pol frameshift region
whereas a smaller effect was seen with sequences from relatively unstructured regions. NC
finger mutant 1.1 was able to greatly enhance transfer and 2.2 had a lesser effect on gag-pol,
while both had a similar effect on an unstructured region from the env gene [135]. All of the
NC mutants were assayed to determine if and to what extent (relative to wt NC) they can
stimulate strand transfer. This would further allow us to assess the importance of specific NC
amino acids. In this case their direct role in the recombination process, rather than just
unwinding will be tested. We hypothesized that there will be a correlation between NC’s
unwinding activity and stimulation of strand transfer on the gag-pol region. Results show that
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isoleucine at position 24 and asparagine at position 27 contribute most significantly to the
difference between the two fingers with respect to chaperone activity.
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2.2 Materials
DNA oligonucleotides for the fluorescence resonance energy-transfer (FRET) assays and
hybrid gel-shift annealing assays were purchased from Integrated DNA Technologies
(Coralville, IA). T4 polynucleotide kinase, Klenow polymerase and RNase-free DNase I
were from New England Biolabs (Ipswich, MA). SP6 polymerase, dNTPs, DNase-free
RNase and calf intestinal alkaline phosphatase (CIP) were from Roche Applied Science
(Indianapolis, IN). RNase inhibitor (RNasin) was from Promega Corp. (Madison WI).
Radiolabeled [γ-32P] ATP was obtained from Amersham Biosciences (Piscataway, NJ).
Sephadex G-25 spin columns were from Harvard Apparatus (Holliston, MA). DE-81 filters
and cellulose nitrate membrane filters were from Whatman Inc. (Florham Park, NJ). PCR
primers for the strand transfer assay were purchased from Integrated DNA Technologies
(Coralville, IA). Plasmid pNL4-3 which is a complete HIV-1 proviral clone derived from
NY5 and LAV strains was purchased from NIH AIDS Research and Reference Reagent
Program. All other chemicals were from Sigma Aldrich (St. Louis, MO) or Fisher Scientific
(Pittsburgh, PA). Recombinant HIV-RT was purchased from Worthington Biochemical Corp.
(Lakewood, NJ). Aliquots of HIV-RT were stored at 80°C, and a fresh aliquot was used for
each experiment. All other chemicals were from Sigma Aldrich (St. Louis, MO) or Fisher
Scientific (Pittsburgh, PA).
Preparation of wt and mutant HIV-1 NC proteins: Wild-type HIV-1 NC from either the
MN strain (GenBank accession number: M17449), the ARV strain or pNL4-3 was used in
this study. Wild-type MN NC was expressed and purified as described [136]. The construct
that expresses wt ARV NC (GenBank accession number: K02007) was graciously provided
by Dr. Charles McHenry (University of Colorado) and this protein was prepared as described
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previously [107]. Wild type and mutant NC proteins from the pNL4-3 sequence (GenBank
accession number AF324493) were prepared essentially as described [75]. For the mutant
NC proteins, the following sequence changes were made in the gene coding for NC (at the
nucleotide level of the pNL4-3 sequence): F16W (t1967g/c1968g), N17K (t1971a), I24Q
(a1990c/t1991a), I24E (a1990g/t1991a), A25M (g1993a/c1994t/c1995g), N27D
(a1999g/t2001c), and mutants with multiple changes were made with combinations of the
above listed changes. The three wt NC proteins differ by no more than five amino acids,
which are all functionally conserved. NC aliquots were stored at -80°C in 50 mM Tris-HCl
(pH 7.5), 10% glycerol, and 5 mM 2-mercaptoethanol.
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2.3 Methods
FRET assay to detect DNA/DNA annealing: The 5’ends of DNA oligonucleotides
were tagged with a fluorescein-6-carboxamidohexyl (FAM) label. The complementary
DNAs were obtained with a 4-[[(4-dimethylamino) phenyl]-azo] benzenesulfonicamino
(DABCYL) moiety at the 3’ends. Annealing experiments were carried out using a Cary
Eclipse fluorescence spectrophotometer (Varian, Inc., Palo Alto, CA). The final
concentrations of the FAM and DABCYL DNAs were 5 and 10 nM respectively. FAM
and DABCYL complements in the presence or absence of 2 µM wt NC/mutant NC
protein, were separately preincubated in 35 µl of buffer containing 50 mM Tris-HCl (pH
8.0), 1 mM dithiothreitol (DTT), 6 mM MgCl2, 80 mM KCl, and 25 µM ZnCl2 for 5 min
at 30°C. The solutions were then mixed in a quartz cuvette to start the time course
reaction. The time course was monitored over 4 min for the unstructured (0.0dna) and the
5.8dna substrates. With the 9.0dna significant annealing could be observed only by
16min. The FAM molecule was excited at 494 nm and fluorescence emissions were
observed at 520 nm. Recordings were made every 10s for the 4 min and every minute for
the 16 min time course. The intensity ratio (Ir) was obtained by dividing the peak
intensity at every time point (It) by the peak intensity observed at time zero (Io). Plots of
Ir vs. time were then constructed. Annealing assays with each wt NC and NC mutants
were performed at least three times and an average of the results was used for
constructing the plots.
Oligonucleotides used for hybrid gel-shift annealing assay: Some of the NC
mutants were also tested in a 7.5rna/dna hybrid system. The RNA for this assay was
transcribed from its DNA oligonucleotide pair. One of the DNAs contained an SP6
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promoter at its 5’end, followed by the DNA sequence of the 7.5rna. This was named
61mer DNA. The shorter DNA complement of the above without any promoter sequence
was called 42mer DNA.
Preparation of 7.5rna/dna hybrid: A hybrid was made between 20 pmoles of the
61mer and 40 pmoles of the 42mer 7.5dna substrates in 50mM Tris-HCl (pH 8.0), 80 mM
KCl and 1 mM DTT. The donor/primer reaction was heated to 65-70˚C for 5 min and
then slow cooled to room temperature. Klenow polymerase was used to fill in the
5’overhang (due to the promoter sequence in the 61mer) in the hybrid. The hybrid made
from above was incubated with 200 µM dNTPs and 10 units of Klenow polymerase. It
was then extracted with phenol:chloroform:isoamyl alcohol (25:24:1) and precipitated
with ethanol.
Preparation of 7.5rna substrate: Double-stranded hybrid DNA obtained as above
was used to generate 7.5rna transcripts with SP6 RNA polymerase using the
manufacturer’s protocol. The following reagents were used at the indicated final
concentrations: 40 mM Tris-HCl pH 8.0, 10 mM DTT, 2 mM spermidine, 6 mM MgCl2,
2 units/µL RNasin (RNase inhibitor) and 1 mM dNTPs. The transcription reaction was
carried out at 37ºC for two hours. The transcription products were digested with 20 units
of RNase-free DNase I for 15 min to remove any remaining template DNA. Equal
volume of 2X formamide dye (90% formamide, 10 mM EDTA (pH 8.0), 0.1% xylene
cyanol and 0.1% bromophenol blue) was then added. The sample was then denatured by
heating between 95-100ºC for 3-5 min and electrophoresed on an RNase-free 10%
denaturing polyacrylamide gel. Excised gel slices containing the RNA were eluted
overnight in 550 µl of RNA elution buffer (80% formamide, 400 mM NaCl, 1 mM
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EDTA, 40 mM Tris-HCl (pH 7.0)). The eluate was then filtered through a 0.45 µm
cellulose acetate syringe filter and precipitated with two volumes of chilled absolute
ethanol.
Dephosphorylation of 7.5rna: 50 pmoles of RNA was dephosphorylated with CIP
for one hour at 37ºC and processed according to the manufacturer’s protocol. It was then
extracted with phenol:chloroform:isoamyl alcohol (25:24:1) and precipitated with
ethanol. The 7.5rna was then quantified by measuring absorbance at 260 nm in a
Pharmacia Biotech Gene Quant II RNA/DNA spectrophotometer (Piscataway, NJ).
5’end-labeling of 7.5rna: Fifty pmoles of the dephosphorylated 7.5rna was
labeled at the 5'-end with [γ-32P] ATP using T4 polynucleotide kinase according to the
manufacturer’s protocol. The RNA was then gel-purified on a 10% RNase-free
denaturing polyacrylamide gel, excised, eluted and precipitated as described previously.
It was then resuspended in 70µl of 10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0) (TE
buffer). The RNA was then quantified spectrophotometrically as described earlier.
RNA/DNA hybrid gel shift annealing assay: The end-labeled 42mer 7.5rna and its
DNA complement were separately subjected to a heat snap reaction. This involved
heating them to 90ºC for 3 min and placing them on ice immediately. The substrates were
allowed to incubate on ice for at least 5 min. The final concentrations of RNA and DNA
were 5nM and 10nM respectively. The 7.5rna and DNA complements were separately
preincubated in the presence or absence of 2µM wt/mutant NC proteins in 50 mM Tris-
HCl (pH 8.0), 1 mM DTT, 0.1 mM EDTA (pH 8.0), 6 mM MgCl2, 80 mM KCl, and 100
µM ZnCl2 for 2 min at 37°C. 17µl of DNA/NC solution was added to 90µl of RNA/NC
solution to start the time course reaction. Fifteen µl aliquots were taken out at 0, 0.25,
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0.5, 1, 2 and 4 min and stopped by the addition of 7.5µl of stop solution (20% glycerol,
0.25% bromophenol blue, 0.2% SDS, 20 mM EDTA (pH 8.0) and 0.4mg/ml yeast
tRNA). They were then incubated for an additional one min at 37˚C before being
transferred to ice.
Gel electrophoresis: The samples were then resolved on 15% native,
polyacrylamide gels. Dried gels were imaged and quantified using a Bio Rad GS-525
phosphorimager.
Annealing assay with 9.0dna: Gel-shift annealing assays were also carried out
with the 9.0dnas which were used in FRET assays. Only some mutants were analyzed in
order to confirm the findings got from FRET assays. In this case, the 9.0dna containing
the DABCYL group at the 3’end was 5’end-labeled with [γ-32P] ATP as described earlier.
The final concentrations of the labeled DABCYL DNA and its complement were 5nM
and 10nM respectively. The annealing assay was performed as before except that in this
case the annealing reaction was carried out over 16min. Fifteen µl aliquots were taken out
at 0, 1, 2, 4, 8 and 16 min and stopped as before. Samples were then electrophoresed,
dried and imaged.
0.0dna end labeling for filter binding assay: Fifty pmoles of the 0.0dna was
labeled at the 5'-end with [γ-32P] ATP using T4 polynucleotide kinase according to the
manufacturer’s protocol. The labeled DNA was then passed over a hydrated Sephadex G-
25 spin column to remove any random dNTPs, and processed according to the
manufacturer’s protocol, then stored at -20ºC.
End labeling of 16.3dna for filter binding assay: The 16.3dna (9.0dna without the
DABCYL group) without the promoter sequence (42 mer) was used in these experiments.
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Fifty pmoles of the DNA was end-labeled with [γ-32P] ATP as described above and used
in filter binding assays.
Nitrocellulose filter binding assay to monitor binding of wt and mutant NC
proteins to nucleic acids: Figure 2-17 shows a schematic diagram illustrating the
nitrocellulose filter binding assay. Whatman nitrocellulose membrane filters with a pore
size of 0.2 µm were presoaked for 15 min in nitrocellulose binding buffer (NB buffer: 50
mM Tris-HCl (pH 8.0), 1 mM DTT, 6 mM MgCl2, 80 mM KCl, and 25 µM ZnCl2). NC
(0.047-2 µM) was mixed with 0.0dna (1 nM) in 10 µl of NB buffer plus 0.1 µg/µl BSA
and incubated for 5 min at room temperature. The entire reaction was spotted onto the
center of a freshly-presoaked nitrocellulose membrane filter. The filter was then
subjected to vacuum and washed 3× with 1 ml of wash buffer consisting of 10 mM Tris-
HCl (pH 8.0) and 10 mM KCl. The filters were then air dried. The dried filters were
counted using a LKB Wallac 1209 Rackbeta liquid scintillation counter. The fraction of
the total substrate that bound to the nitrocellulose filter was then calculated as follows:
The counts obtained for each concentration of NC used was initially subtracted from
background (determined using a reaction without NC). This value was then divided by
the total counts added to the reaction (calculated by counting a reaction applied to a
DE81 filter that was not presoaked or washed) to obtain the fraction of the total substrate
bound. A plot of fraction substrate bound vs. NC concentration in the reaction was then
constructed for each NC protein.
PCR amplification of DNA substrates for strand transfer assays: Two sets of
primers were designed to generate the donor and acceptor RNAs derived from the pNL4-
3 plasmid. An SP6 promoter sequence (shown in bold) was added to the forward primer
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along with 5 additional non homologous nucleotides (shown in italics) to prevent transfer
of DNA products from the end of the donor to the acceptor (See Table 2-5). One hundred
pmoles of each primer was used in the PCR reactions in a volume of 100 µl including 0.1
µg plasmid DNA, 5 units Taq polymerase, 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5
mM MgOAc. The cycling parameters used were as follows: 35 cycles of successive
denaturation, annealing and extension reactions were carried out for 1 min each at 94, 50
and 72˚C, respectively. This was followed by one 5 min extension cycle at 72˚C. The
PCR products were then resolved on an 8% native polyacrylamide gel. Excised gel slices
containing DNA were eluted overnight in 550 µl of 10 mM Tris-Cl (pH 7.5), 1 mM
EDTA. The eluate was filtered through a 0.45 µm cellulose acetate syringe filter and
DNA was precipitated with two volumes of ethanol and 1/10th volume 3 M NaOAc (pH
7.0) and resuspended in water.
Preparation of RNA substrates: DNA products obtained by the PCR method
described above were used to generate donor and acceptor RNA transcripts with SP6
RNA polymerase using the manufacturer’s protocol. Approximately two µg of the
purified PCR DNAs were used. The transcription products were digested with 20 units of
RNase free DNase I for 15 min to remove any remaining template DNA. Reactions were
then extracted with phenol:chloroform:isoamyl alcohol (25:24:1) and precipitated with
ethanol. The pellet was resuspended in 70 µl of water and centrifuged through two
successive hydrated G-25 spin columns and processed according to the manufacturer’s
protocol. The RNA was then quantified by measuring absorbance at 260 nm in a
Pharmacia Biotech Gene Quant II RNA/DNA spectrophotometer (Piscataway, NJ). The
integrity of the RNAs was analyzed to ensure it was comprised of predominately fully
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extended RNAs by running approximately 40 pmoles on an 8% denaturing
polyacrylamide gel and staining with ethidium bromide.
End labeling of PCR primer for strand transfer assay: Fifty pmoles of the DNA
primer that bound specifically to the donor RNA was labeled at the 5'-end with [γ-32P]
ATP using T4 polynucleotide kinase according to the manufacturer’s protocol. The
labeled primer was then passed over a hydrated Sephadex G-25 spin column to remove
any random dNTPs and stored at -20ºC.
Preparation of RNA/DNA hybrid: The donor RNA and the labeled primer DNA
were mixed in 10 µl of 50 mM Tris-HCl (pH 8.0), 1 mM DTT and 80 mM KCl. The
donor:primer ratio used was 1:5. The donor/primer reaction was heated to 65-70˚C for 5
min and then slow cooled to room temperature.
Strand transfer assay and NC time course reaction: Hybrids from above were
preincubated with acceptor RNA in the presence/absence of wild-type or mutant NC
proteins for 1 min in 42 µl of reaction buffer (described below). HIV-1 RT (8 µl at 0.5
pm/µl) was added to start the time course. Final concentrations of reagents in the
reactions were: 80 nM RT, 2 nM donor-10 nM primer, 10 nM acceptor, 2 µM NC, 50
mM Tris-HCl (pH 8.0), 80 mM KCl, 6 mM MgCl2, 5 mM AMP (adenosine
monophosphate) (pH 7.0), 1 mM DTT, 25 µM ZnCl2, 100 µM dNTPs, and 0.4 units/µl
RNasin. Six µl aliquots were taken out at 2, 4, 8, 16, 32 and 64 min and stopped by the
addition of 4 µl of 25 mM EDTA (pH 8.0) and 5 ng of DNase-free RNase and incubated
for additional 15 min at 37˚C. Two µl of proteinase-K solution (2mg/ml proteinase-K, 10
mM Tris-HCl (pH 8.0), 15 mM EDTA (pH 8.0), 1.25% SDS) was then added to all of the
samples, which were incubated at 65˚C for 45 min to digest protein. Twelve µl of 2X
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formamide dye (90% formamide, 10 mM EDTA (pH 8.0), 0.1% xylene cyanol and 0.1%
bromophenol blue) was then added to each sample. The samples were electrophoresed on
8% denaturing polyacrylamide gels. Dried gels were imaged and quantified using a Bio
Rad FX Pro Plus molecular imager with Quantity One software (Hercules, CA).
Gel electrophoresis: Native 8% polyacrylamide gels (for purification of PCR
products) and denaturing 8% polyacrylamide gels containing 7M urea (for resolving
strand transfer products) were prepared as described in the manufacturer’s protocol and
subjected to electrophoresis.
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2.4 Results of Fluorescence resonance energy transfer (FRET) and gel
shift assays with wt NC and NC mutants
FRET assay to detect nucleic acid annealing: Fluorescence resonance energy
transfer (FRET) was used to detect annealing between non-structured and structured
nucleic acid complements. FRET is defined as “the non-radiative transfer of photon
energy from an excited fluorophore (the donor) to another fluorophore (the acceptor)
when both are located within close proximity”. However, FRET can be carried out only
under certain conditions:
1. The two fluorophores must be within 10-100Aº.
2. The emission spectrum of the donor must overlap with the excitation spectrum of
the acceptor.
3. Both donor and acceptor molecules should be in their excited energy states.
4. The transition dipole orientations of the two fluorophores must be nearly parallel.
The efficiency of FRET is inversely proportional to the sixth power of intermolecular
separation thereby making it a very useful tool to detect changes in proximity over
distances comparable to macromolecular dimensions. When donor/acceptor pairs are
different, FRET can be monitored either by the sensitized appearance of fluorescence of
the acceptor or by the quenching of donor fluorescence. When they are the same, FRET
can be detected by the depolarization of the resulting fluorescence. FAM (fluorescein-6-
carboxamidohexyl) and DABCYL (4-[[(4-dimethylamino) phenyl]-azo] benzenesulfonicamino)
were the fluorophore and quencher molecules that we used in our FRET assays. The
FAM molecule was excited at 494 nm and fluorescence emissions were observed at 520
nm. The emission spectrum of FAM overlaps with the excitation spectrum of DABCYL
(See Fig 2-1). The 5’end of the donor is tagged with FAM and the 3’end of the acceptor
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is tagged with DABCYL (See Fig. 2-2). The donor and acceptor were each 42
nucleotides and were completely complementary. As annealing progresses, the
fluorescence emitted by FAM would be quenched by DABCYL. Thus, a decrease in
fluorescence intensity would correlate to hybridization between the two oligonucleotides.
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Figure 2-1: Schematic diagram of FRET
Shown is a schematic diagram of FRET. J(λ) indicates the spectral overlap integral
function. J(λ) is plotted as a function over wavelength (λ) in nm. FRET can occur only
when the donor emission wavelength spectrum overlaps with the acceptor excitation
spectrum. The blue region represents the spectral overlap between the donor fluorescence
(emission) and acceptor absorbance (excitation). Figure obtained from “Technical Focus:
Fluorescence Resonance Energy Transfer (FRET)” maintained by Invitrogen
(http://probes.invitrogen.com/handbook/boxes/0422.html).
56
Figure 2-2: Schematic model of FRET assay
Shown is a schematic model of the FRET assay used. The 5’end of the donor
oligonucleotide was tagged with a FAM molecule (green square), while the 3’end of the
acceptor was tagged with a DABCYL molecule (orange circle). During annealing, the
two oligonucleotides come into close proximity with each other. Hence, fluorescence
emitted by FAM would be quenched by DABCYL.
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Structure of DNA substrates used for annealing assay: All of the DNA substrates
were 42 nucleotides in length but differed in sequence composition. These structures
were determined using mfold. RNA versions of these substrates had been used in earlier
experiments [91]. The predicted folded structures are shown in Fig. 2-3. Note that only
one of the two complementary strands is shown for each substrate. The Gibbs free energy
of unfolding is indicated next to the corresponding structure and each structure is referred
to throughout the text by the energy value followed by “dna” (for example, 9.0dna). All
of the substrates formed a stem-loop except 0.0dna which had no predicted structure. The
binding strength of the stem in the substrates was increased from one substrate to the
next. Successive GT repeats were avoided, since NC has been shown previously to have a
preference for GT repeats. Because of the stem-loop structure of the substrate, the
complementary strands must be unwound before they can completely hybridize. The
assay essentially tests NC’s ability to facilitate annealing by aiding in the unwinding
process. Substrate 0.0dna tests the ability of NC to accelerate annealing in the absence of
structure. In this case the aggregation/condensation activity of NC is presumably
responsible for the observed rate increase.
Annealing assays performed with wt and NC finger mutants: Work previously
done in this and other laboratories has shown that the first zinc finger of NC is primarily
responsible for unwinding nucleic acid secondary structures (helix-destabilizing activity),
while the second finger plays an accessory role [91]. Finger mutants in which the CCHC
zinc coordinating amino acids in the fingers were replaced by SSHS were tested for their
unwinding activities. Three SSHS mutants were used; SSHS1 had the three cysteines in
finger one replaced by three serine residues, SSHS2 had the three cysteines in its second
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Figure 2-3: 42mer DNA substrates used for annealing assays
Shown are the DNA substrates used in the FRET annealing assays. Only one of the
oligonucleotide pairs is shown. All of them are 42 nucleotides in length but differ in their
sequence composition. The binding strength of the stem in the substrates was increased
from one substrate to the next. All of the substrates formed a stem-loop except 0.0dna
which had no predicted structure. 5.8dna had 14A-T and no G-C base pairs. 9.0dna had
11A-T and 4G-C base pairs. The strongest stem-loop structure, namely 15.8dna contained
8A-U and 7G-C base pairs. The Gibbs free energy of unfolding is indicated next to each
structure. Each structure is referred to throughout the text by the energy value followed
by “dna” (for example, 9.0dna). The ∆G values for the complementary sequences were -
0.3, -1.2, and -6.6 for 0.0dna, 5.8dna and 9.0dna, respectively. In cases where more than
one structure was predicted, the ∆G for the most stable structure is reported. Concentric
circles indicate the 5’ends. Successive GT repeats were avoided since NC is known to
bind preferentially to GT sequences.
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zinc finger replaced with serine residues, and SSHSd had the cysteines in both fingers
replaced with serines. These SSHS finger mutants allowed us to confirm previous
findings about roles of the fingers with respect to annealing and helix destabilization. In
addition, NC finger mutants 1.1 and 2.2 were also tested (See Sec 2-1). Annealing was
detected by FRET as described under Sec 2-3. Assays were performed with mutant and
wild-type NC proteins using the various substrates.
The role of the two zinc fingers of NC was previously investigated in our
laboratory on an rna/dna hybrid gel shift annealing assay. However we decided to test
them using the dna/dna FRET-based system because it is faster and easier to manipulate.
The FRET system also allows “real-time” analysis of annealing because the sample is
monitored on a scale of seconds rather than minutes in the gel assay. Figure 2-4 and
Table 2-1 show the effect of NC finger mutants on 0.0dna. For each NC protein and DNA
substrate, a rate constant for complement annealing was calculated by fitting the intensity
profile data to a semi-logarithmic plot [72]. This is illustrated for one of the point mutants
and wt NC in Fig. 2-11. With the unstructured substrate, the complementary nucleotides
annealed very rapidly even in the absence of NC, and NC clearly enhanced annealing
even further resulting in about a 2-fold increase in the rate constant (See Table 2-1 and
Fig 2-4 also). This demonstrates NC’s ability to enhance annealing even in the absence of
secondary structure, presumably by aggregation/condensation. All of the mutants also
stimulated annealing with this substrate in comparison to reactions without NC. There
were some differences with SSHSd and 2.2 showing the least stimulation; however, all
mutants appeared to retain aggregation/condensation activity based on this assay. This is
consistent with the idea that this activity results mostly from the highly positively
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charged NC backbone amino acids that act to neutralize negative charges on the
phosphate backbone of nucleic acids.
Shown in Tables 2-2 and 2-4 are the rate constants for NC proteins on structured
DNA substrates (5.8dna and 9.0dna). Very little annealing was observed in reactions
without NC and no rate values were obtained. All the finger mutants showed some
stimulation. In general the annealing rates were about 4-7 fold slower on 9.0dna than
5.8dna reflecting the greater stability of the former. Consistent with previous results, NC
mutants without an active finger one (2.2, SSHS1, and SSHSd) were clearly more
defective in helix destabilization. These mutants showed an annealing rate about 20-30%
of the wt NC level. These results support earlier findings indicating that the first zinc
finger of NC is required for efficient unwinding of strong secondary structures. Further,
the various SSHS mutants behave very similarly to the corresponding finger mutants that
contain only one of the two zinc finger sequences (1.1 and 2.2).
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Figure 2-4: FRET assay with NC finger mutants on 0.0dna
FRET assays were carried out at 30ºC in the absence or presence of wt or finger mutant
NC proteins (1.1, 2.2, SSHS1, SSHS2, and SSHSd) as described in “Methods”. The 5’-
FAM derivatized DNA (5 nM final) substrates and 3’- DABCYL derivatized (10 nM
final) complements were separately preincubated in the presence of wt or finger mutant
NC proteins (2 µM final concentration). These were mixed to start the annealing reaction.
Fluorescence was monitored over time using a fluorescence spectrophotometer. The
Intensity ratio (Ir) (fluorescence intensity at each time point (It) divided by fluorescence
intensity at time zero (Io)) is plotted versus time (See “Methods”). Recordings were made
every 10s throughout the 4 min time course. A control reaction in which no
complementary DABCYL DNA was present was also performed. The line shown
represents an average from at least three experiments.
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Figure 2-5: FRET assay with NC finger mutants on 9.0dna
Shown above is the FRET assay performed with NC finger mutants on 9.0dna. The assay
was carried out as described above (Fig 2-4), except that recordings were made every
1min during the 16min time course.
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wt NC 0.598 1.16 ± 0.0492
-NC 1.27 0.549 ± 0.0458
SSHS2 0.592 1.18 ± 0.106
SSHS1 0.654 1.06 ± 0.0454
SSHSd 0.813 0.863 ± 0.111
1.1 0.625 1.11 ± 0.0466
2.2 0.634 1.11 ± 0.133
F16W 0.678 1.02 ± 0.0493
N17K 0.586 1.18 ± 0.0193
I24Q 0.602 1.15 ± 0.0321
A25M 0.736 0.957 ± 0.149
N27D 0.760 0.928 ± 0.135
F16WI24Q 0.875 0.792 ± 0.0101
F16WN27D 0.845 0.838 ± 0.171
F16WI24QN27D 0.734 0.949 ± 0.101
1-HIV strain pNL4-3 NC was used as backbone for making NC mutants. The
SSHS mutants replace the CCHC zinc binding motif with SSHS in finger 2
(SSHS2), finger 1 (SSHS1), or both (SSHSd). 1.1 and 2.2 are mutants with two
copies of finger 1 or 2.
2-k (rate constant) values were calculated from the t1/2 values by dividing 0.693
by t1/2 as described above in Fig. 2-11. Results are an average of 3-4 experiments
± standard deviations (shown for k only). Although experiments were performed
over 4 min, only values from the first min were used in calculations due to the
rapid kinetics resulting in saturation.
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Table 2-2. Rate constant (k) calculation for NC proteins on
5.8dna substrate
1Name 25.8dna 25.8dna (1 mM
Mg2+)
-NC ND ND
wt NC 0.161 ± 0.0049 0.733 ± 0.019
SSHS2 0.149 ± 0.0231 ND
SSHS1 0.048 ± 0.0009 ND
SSHSd 0.026 ± 0.0024 ND
1.1 0.097 ± 0.0200 ND 
2.2 0.038 ± 0.0017 ND
F16W 0.191 ± 0.0287 ND
N17K 0.162 ± 0.0212 0.566 ± 0.049
I24Q 0.069 ± 0.0076 0.281 ± 0.010
A25M 0.109 ± 0.0347 ND
N27D 0.049 ± 0.0017 0.170 ± 0.022
F16WI24Q 0.057 ± 0.0122 ND
F16WN27D 0.058 ± 0.0218 ND
F16WI24QN27D 0.058 ± 0.0355 ND
1-HIV strain pNL4-3 NC was used as backbone for making NC mutants.
The SSHS mutants replace the CCHC zinc binding motif with SSHS in
finger 2 (SSHS2), finger 1 (SSHS1), or both (SSHSd). 1.1 and 2.2 are
mutants with two copies of finger 1 or finger 2, respectively.
2-k (rate constant) values were calculated from the t1/2 values by dividing
0.693 by t1/2 as described earlier. Results are an average of 3-4 experiments
± standard deviations. Experiments were performed with 2 µM NC, 6 mM
MgCl2 and 80 mM KCl in standard buffer except for the 5.8dna (1 mM
Mg2+) column. –NC values were only determined for 0.0dna since no
significant hybridization was observed for the other substrates in the
absence of NC. ND-Not determined.
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Table 2-3. Rate constant (k) calculation using varied [NC] on 5.8dna
substrate1
NC(µM) Wild type N17K I24Q N27D
8 0.383 ± 0.206 0.268 ± 0.012 0.178 ± 0.028 0.184 ± 0.097
4 0.335 ± 0.055 0.356 ± 0.025 0.091 ± 0.003 0.078 ± 0.041
2 0.161 ± 0.005 0.162 ± 0.021 0.069 ± 0.008 0.049 ± 0.002
1 0.082 ± 0.027 0.069 ± 0.016 0.032 ± 0.008 0.034 ± 0.007
0.5 0.043 ± 0.001 0.053 ± 0.005 0.034 ± 0.001 0.019 ± 0.011
1- Refer to Table 2-2 for details.
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wt NC 29.2 0.024 ± 0.001
SSHS2 41.4 0.017 ± 0.001
SSHS1 57.6 0.012 ± 0.001
SSHSd 154 0.005 ± 0.001
1.1 37.8 0.018 ± 0.002
2.2 113 0.006 ± 0.001
F16W 6.83 0.102 ± 0.001
N17K 27.5 0.025 ± 0.002
I24Q 56.1 0.012 ± 0.001
A25M 36.0 0.019 ± 0.001
N27D 56.6 0.012 ± 0.001
F16WI24Q 122 0.006 ± 0.001
F16WN27D 122 0.006 ± 0.001
F16WI24QN27D 160 0.005 ± 0.001
1-HIV strain pNL4-3 NC was used as backbone for making
NC mutants. The SSHS mutants replace the CCHC zinc
binding motif with SSHS in finger 2 (SSHS2), finger 1
SSHS1), or both (SSHSd). 1.1 and 2.2 are mutants with two
copies of finger 1 or finger 2.
2-k (rate constant) values were calculated from the t1/2 values
by dividing 0.693 by t1/2 as described earlier. Results are an
average of 3-4 experiments ± standard deviations (shown for
k only). Experiments were performed with 2 µM NC, 6 mM
MgCl2 and 80 mM KCl in standard buffer. –NC values were
only determined for 0.0dna since no significant hybridization
was observed for the other substrates in the absence of NC.
ND-Not determined.
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Effect of NC point mutants on annealing of structured and unstructured DNAs:
The above experiments confirmed the important role of finger one in helix destabilization
(See Sec 2-1). We next wanted to determine what residues in finger one were responsible
for its unwinding advantage over finger two. Figure 1-7 shows a schematic diagram of
HIV-1 pNL4-3 NC protein. There are five amino acids which differ between the two
finger sequences. These include (finger one to finger two): F to W, N to K, I to Q, A to
M, and N to D at positions 16, 17, 24, 25, and 27 of finger one, respectively. NC point
mutants were constructed where the amino acid residues in finger one were incrementally
replaced by those at the corresponding locations in finger two. Figure 2-6 and Table 2-1
show the effects of various NC point mutants on annealing of the unstructured 0.0dna
detected by FRET. As with the finger mutants a clear distinction was observed between
reactions with and without NC; NC clearly enhances annealing. There was no obvious
difference between the point mutants. This was expected given that the more highly
mutated finger mutants showed no strong differences with this substrate.
Figure 2-7 and Table 2-2 show the effect observed with the point mutants on
5.8dna. On this more strongly folded substrate clear groupings emerged. Mutants N17K
and F16W were able to stimulate annealing as well as wt NC. Mutant A25M showed
some reduction in annealing in comparison to N17K and F16W, but was clearly better
than N27D and I24Q. The latter two showed about a 60-70% rate reduction in
comparison to wt NC.
The same general pattern was observed with the strongest structure, 9.0dna (Fig.
2-8 and Table 2-4). In this case annealing was much slower than with 5.8dna
(approximately 7-fold), and the assay was performed over 16 min rather than 4 min as
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with 0.0dna and 5.8dna. Once again N17K was similar to wt NC and A25M showed a
small reduction in activity. Mutants N27D and I24Q showed reduced stimulation with
about 50% the rate of wt NC. Interestingly, the F16W mutant annealed much better than
even wt NC showing about a 4-fold increase in annealing rate (Fig. 2-9). This was also
the case for an even stronger 42 nucleotide DNA substrate (15.8dna) that folded with a
∆G value of -15.8 kcal/mole (Fig 2-3). On this substrate wt NC stimulated annealing less
than half as well as F16W (Fig 2-10).
Optimal magnesium concentrations (6 mM) for reverse transcriptase assays were
used in the above described experiments. However, the concentration of non-complexed
magnesium in cells may be much lower and results have shown that NC is more active
with lower ionic strength. Wild type, N17K, I24Q, and N27D NC proteins were also
tested using 1 mM magnesium on 5.8dna (Table 2-2). As expected the annealing rates
increased about 3-4 fold with the lower magnesium concentration. Differences between
the wt and mutant NC proteins remained consistent at both concentrations, indicating that
the magnesium concentration was not a factor in this observation.
An NC titration was also performed using 5.8dna and each of the above mutants
(Table 2-3). For wt NC, the rate of annealing was proportional to the [NC] up to 4 µM
NC. Increasing to 8 µM had little effect. This was also observed with N17K. The more
defective mutants (I24Q and N27D) also showed proportional increases but did not
saturate at 4 µM NC. For both mutants rate values at a given NC concentration were
always significantly lower than wt NC.
Effect of double and triple mutants on annealing of structured and unstructured
DNAs: Results from the single point mutants in annealing assays showed that two of the
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mutants, N17K and A25M, were comparable to wt NC with the latter being slightly less
stimulatory. In contrast, I24Q and N27D mutants were strongly inhibitory while F16W
showed enhanced activity on highly structured substrates. Therefore, of the five different
amino acids between fingers one and two, only two (I24 and N27) seemed to be
important to finger one’s advantage in helix-destabilization. One change (F16W) actually
indicated that finger two has a more effective amino acid for helix-destabilization at that
position. It is important to note that single point mutations ignore the possibility of
“context effects” in contributing to the activities of the fingers. A particular amino acid
could function differently in the context of one group of amino acids vs. another. Testing
all combinations of mutations in which amino acids in finger one are replaced by
corresponding ones from finger two, would require 30 separate mutants, many of which
would yield little information. We took a directed approach based on the results from the
single mutants. Our working hypothesis was that the changes at positions 24 and 27 cause
finger one to lose helix-destabilizing activity and these would have “dominant negative”
effects with respect to the apparent gain in activity from the F16W change. This would
explain why finger two (as judged from mutants 2.2 and SSHS1) shows little
destabilizing activity. To test this, two double mutants (F16W/I24Q and F16W/N27D)
containing the positive change along with each negative change, and a triple mutant
(F16W/I24Q/N27D) which combined the positive mutant with both negatives were
constructed.
On the non-structured 0.0dna substrate (Table 2-1) the double and the triple
mutants displayed a very similar annealing pattern with a slightly slower rate than wt NC
but a clear increase over reactions without NC. Again, the results suggest that the mutants
70
retain most of the aggregation/condensation activity of NC. In contrast, the double and
triple mutants were all highly defective on the structured substrates (Tables 2-2 and 2-4).
These mutants were comparable to 2.2 and SSHSd on the structured substrates. Overall
the results support the dominant negative hypothesis and suggest that I24 and N27 are
pivotal to the helix-destabilizing function of finger one. Changes in either position to the
corresponding amino acid in finger two lead to significant decreases in helix
destabilization while changing both essentially mimics replacing finger one with finger
two (2.2) or deactivating finger one (SSHS1). These changes also completely mask the
strong destabilizing activity of the phenylalanine to tryptophan mutation at position 16 of
finger one (F16W).
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Figure 2-6: Effect of NC point mutants on annealing of 0.0dna
Shown is the FRET assay done with NC point mutants on 0.0dna. Experiments were
performed as described earlier (See Fig. 2-4).
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Figure 2-7: Effect of NC point mutants on annealing of 5.8dna
Shown above is the FRET assay done with NC point mutants on 5.8dna. Experiments
were carried out as before (See Fig 2-4). Assays with wt NC or without NC are also
shown.
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Figure 2-8: FRET assay with NC point mutants on 9.0dna
Shown above is the effect of NC point mutants on annealing of 9.0dna detected by FRET.
Recordings were made every min during the entire 16min time course. The assay was
performed as described earlier (See Fig 2-4).
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Figure 2-9: Binding of F16W to 9.0dna detected by FRET
Shown above is the effect of the F16W mutant on annealing of 9.0dna detected by FRET.
Recordings were made every min during the entire 16min time course. The assay was
performed as described earlier (See Fig 2-4).
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Figure 2-10: Effect of NC point mutants on annealing of 15.8dna
Shown is the effect of NC point mutants on annealing of 15.8dna. The assay was
performed as described previously except that recordings were made every min
throughout the 32min time course (See Fig 2-4).
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Figure 2-11: Semi-log plot of the intensity profile of N27D mutant
Shown above is a semi-log plot of the reaction with wt and N27D NC constructed from
the trace shown in Fig. 2-8. The Ir value from the graph was plotted on a log scale vs.
time and the data points were fit to a straight line using linear regression analysis (Sigma
Plot). The slope of the line was used to determine the t1/2 value of the reaction and the
equation k=0.693/t1/2 was used to calculate the rate constant k [72]. At least three
independent k values were obtained for each mutant on each substrate. Rate constant
values for this particular experiment are shown next to each line. The average values +/-
standard deviations are shown in Tables 2-1 through 2-4.
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Figure 2-12: Effect of NC double and triple mutants on annealing of 0.0dna
Shown is the FRET assay done with NC double and triple mutants on 0.0dna.
Experiments were performed as described earlier (See Fig. 2-4).
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Figure 2-13: Effect of NC double and triple mutants on annealing of 5.8dna
Shown is the FRET assay done with NC double and triple mutants on 5.8dna.
Experiments were performed as described earlier (See Fig. 2-4).
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Figure 2-14: Effect of NC double and triple mutants on annealing of 9.0dna
Shown is the FRET assay done with NC double and triple mutants on 9.0dna.
Experiments were performed as described earlier (See Fig. 2-4).
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Gel-shift annealing assays performed with 7.5rna/dna system: Annealing assays
were also completed with some of the NC mutants on the 7.5rna/dna hybrid system as
described under “Methods” (See Fig 2-15). This substrate is the RNA form of the 5.8dna
substrate prepared as described before. Annealing was monitored between the 7.5rna and
its DNA complement over 4 min. Note that this substrate is named 7.5rna due to higher
∆G value of unfolding which reflects more stable folding of RNA vs. DNA. Besides wt
NC, the following NC mutants were also tested using the gel-shift assay: SSHS1, SSHS2,
N17K, I24E and A25M. N17K, A25M and SSHS2 mutants were able to promote
RNA/DNA hybridization close to wt NC levels, while SSHS1 and I24E showed highly
reduced stimulation. These observations clearly support our findings from the FRET
assays.
Gel-shift annealing assays performed with 9.0dna/dna system: Shown in Fig 2-16
are autoradiograms of annealing assays performed with N17K, A25M, F16WI24QN27D,
F16WN27D and F16WI24Q NC mutants on the 9.0dna/dna system. These experiments
were carried out as described under the “Methods” section. While N17K and A25M
clearly enhanced annealing close to wt NC levels, both double and triple mutants were
less stimulatory. Once again, these results correlated with our findings from the FRET
assays. The appearance of another band above the DNA/DNA hybrid species can be seen
in Fig 2-16. This most likely represents a DNA/DNA dimer since it is more prominent in
reactions with one of the oligonucleotide pairs. The moderate stability of dimers, though
lesser than hybrids enables them to form quite easily.
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Figure 2-15: Autoradiograms of annealing assays on 7.5rna with NC mutants
Shown in the panel above are autoradiograms obtained from annealing assays performed
with NC mutants on the 7.5rna/dna hybrid system. Annealing assays were performed
over 4min as described in “Methods”. The time course was monitored at 0, 0.25, 0.5, 1, 2
and 4 min. The positions of ssRNA and RNA/DNA hybrids are also indicated. C denotes
control reactions that were carried out in the absence of complementary 7.5dna over the
4min time course.
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Figure 2-16: Autoradiograms of annealing assays done with 9.0dna
Shown in the panel above are autoradiograms obtained from the 9.0dna/dna hybrid
annealing assays. These assays were performed as described before. The positions of
single-stranded DNA (ssDNA), DNA/DNA dimers (dimer), and DNA/DNA hybrids
(D:D) are also indicated. C is the control sample containing the labeled DABCYL 9.0dna
and NC/NC mutant, but no complementary DNA.
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2.5 Results of binding affinity analysis for binding of NC and NC
mutants to nucleic acid substrates
Binding of NC mutants to 0.0dna detected by nitrocellulose filter binding assay:
One possible reason for the observed defects in some of the mutants could be reduced
binding affinity for the substrate nucleic acid. To determine if any of the mutations
affected the affinity of NC for DNA, filter binding assays were performed. Graphs
obtained by plotting the fraction of total amount of substrate in the assay that bound to
nitrocellulose filters at various NC concentrations are shown in Figs. 2-18 through 2-20.
The FAM-derivatized complement of 0.0dna made without the FAM group and 5’ end
labeled with P-32 was used for these assays. SSHSd NC mutant showed the lowest
binding affinity (See Fig 2-18). This NC mutant had the cysteine residues in both fingers
replaced with serines. This assay allowed us to confirm previous findings about roles of
the fingers with respect to DNA binding. Our result clearly supports earlier findings that
the presence of zinc fingers is an absolute requirement for nucleic acid binding. The three
mutants that are comparable to wt NC in the annealing assays (F16W, N17K and A25M)
also show similar levels of DNA binding. In contrast, of the mutants that showed reduced
activity in the annealing assays (I24Q, N27D, F16W/I24Q, F16W/N27D, and
F16W/I24Q/N27D), only I24Q (Fig. 2-19) was comparable to wt NC in binding. The
other four showed significantly lower affinity than wt NC (Fig. 2-20). Consistent with
these results, finger mutant 2.2 but not 1.1 showed reduced binding in the assay (data not
shown). It was interesting that the double mutant F16W/I24Q showed reduced binding
despite neither of the single mutants showing reductions. Overall the results indicate that
mutations that reduce NC binding lead to an apparent reduction in helix-destabilizing
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activity as expected. However, this activity is not solely determined by binding as I24Q
binds similar to wt but is defective in helix-destabilization.
Binding of NC mutants to 16.3dna detected by nitrocellulose filter binding assay:
Mutants N27D and I24Q were also compared to wt NC for binding to 16.3dna in filter
binding assays (Figs. 2-21 and 2-22). The apparent binding affinity to this structured
substrate was lower for all the NC proteins as more NC was required to retain a
comparable amount of substrate on the filters. Consistent with binding to 0.0dna, only
N27D showed reduced binding in comparison to wt NC (Fig. 2-21).
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Figure 2-17: Schematic diagram of nitrocellulose filter binding assay
Shown is a schematic diagram of the nitrocellulose filter binding assay. Nitrocellulose
membrane filters are first presoaked in NB buffer (50 mM Tris-HCl (pH 8.0), 1 mM
DTT, 6 mM MgCl2, 80 mM KCl, and 25 µM ZnCl2) for 15min. NC (0.047-2 µM) is
mixed with DNA (1 nM) in 10 µl of NB buffer plus 0.1 µg/µl BSA and preincubated for
5min. The entire reaction is then spotted onto the center of the disc. The filter is then
subjected to vacuum and washed 3× with 1 ml of wash buffer consisting of 10 mM Tris-
HCl (pH 8.0) and 10 mM KCl. The filters are then air dried and counted using a LKB
Wallac 1209 Rackbeta liquid scintillation counter.
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Figure 2-18: Binding of SSHSd to 0.0dna detected by filter binding assay
Shown above is the binding of SSHSd NC mutant to 5’end labeled 0.0dna detected by
nitrocellulose filter binding assay. The assay is performed as described previously. The
counts obtained for each concentration of NC used was initially subtracted from
background (determined using a reaction without NC). This value was then divided by
the total counts added to the reaction (calculated by counting a reaction applied to a
DE81 filter that was not presoaked or washed) to obtain the fraction of the total substrate
bound. A plot of fraction substrate bound vs. NC concentration in the reaction was then
constructed for each NC protein. A representative experiment is shown and each assay
was repeated at least once.
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Figure 2-19: Binding of F16W, N17K, I24Q, and A25M NC mutants to 0.0dna
Shown above is the binding of F16W, N17K, I24Q and A25M NC mutants to 0.0dna.
The assay is carried out as before and plots are obtained. A representative experiment is
shown and each assay was repeated at least once.
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Figure 2-20: Binding of N27D, F16W/I24Q, F16W/N27D, and F16W/I24Q/N27D NC
mutants to 0.0dna
Shown above is the binding of N27D, F16W/I24Q, F16W/N27D, and F16W/I24Q/N27D
mutants to 0.0dna. The assay is carried out as described previously. A representative
experiment is shown and each assay was repeated at least once.
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Figure 2-21: Binding of N27D to 16.3dna
Shown is the binding of N27D NC mutant to 16.3dna detected by filter binding assay.
The assay is performed as before. The apparent binding affinity to this structured
substrate was lower as more NC was required to retain a comparable amount of substrate
on the filters. Consistent with binding to 0.0dna, N27D showed reduced binding in
comparison to wt NC.
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Figure 2-22: Binding of I24Q to 16.3dna
Shown is the binding of I24Q NC mutant to 16.3dna. The assay was performed as
described earlier. As with 0.0dna, the binding of I24Q is comparable to wt NC.
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2.6 Results of internal strand transfer assays with wt NC and NC
mutants
Strand transfer assay: An in vitro strand transfer assay has previously been used
in our laboratory to investigate recombination in different regions of the genome [135].
Figure 2-23 shows a schematic model of the system. Figure 2-24 depicts a schematic
overview of the experimental approaches used. This assay mimics internal strand transfer
events that occur during minus DNA synthesis in the viral genome. The donor refers to
the template RNA on which DNA synthesis is initiated, while the template on which
donor directed DNA products can potentially transfer to is referred to as acceptor RNA.
Thus, the donor and acceptor RNA templates represent the two RNA strands of the viral
genome. For these experiments, the templates were derived from a highly structured
region of the HIV genome that included the gag-pol frameshift sequence. DNA synthesis
is primed at the 3’end of the donor by a 5’end labeled DNA primer. The donor and
acceptor RNA strands are designed to have a 150 base pair region of homology where
strand transfer can potentially occur. The transfer zone is indicated by a dotted box. Full
length DNA products from DNA synthesis directed by the donor would be 175 nt in
length. Products made after transfer and extension on the acceptor would be 197 nt in
length. The difference in lengths of the DNA products allowed us to locate their relative
positions on denaturing gels. This assay tests for internal strand transfers; hence transfers
from the end of the donor were prevented by adding a 5 nucleotide non-homologous
region to the 5’ end of the donor template. Transfer could also occur between two donor
templates. However, this would be negligible since the amount of acceptor RNA used
was five times in excess over the donor RNA. Further, fewer donor RNA templates
would be available as DNA synthesis proceeds.
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The percent of transfer efficiency was calculated by: {transfer DNA products (T)
/(transfer DNA products (T) + full length donor-directed DNA (F))} x 100. It reflects the
amount of DNA primers that get extended to the end of the acceptor versus those that
undergo donor extension. This number gives us an actual indication of transfer in terms
of total DNA extended, rather than simply giving transfer levels.
Secondary structure prediction using RNAdraw and mfold programs: Secondary
structures of RNA substrates were predicted using RNAdraw and mfold programs [135],
[137]. Figure 2-25 shows the secondary structure prediction of the donor RNA obtained
from the gag-pol frameshift region. The acceptor RNA was predicted to have a similar
structure as the donor (See Fig 2-26). High ∆G and Tm values indicate presence of strong
secondary structures. The gag-pol donor RNA was predicted to have a ∆G value of -45.3
kcal/mole and its predicted stem-loops persisted even at temperatures above 55ºC. The
gag-pol acceptor RNA was predicted to have a ∆G value -37.22 kcal/mole. The A residue
which was determined to be a major pause-site for RT enzyme is also indicated on both
folding diagrams.
Effect of NC mutants on strand transfer: Figures 2-27 through 2-30 show
autoradiograms obtained from strand transfer assays performed with the gag-pol substrate
using the different NC mutants. The positions of transfer (T) and donor-directed products
(D) are indicated as is the primer position (P). In Fig 2-27, the four sets of assays show
reactions (from left to right) without NC, those with wt NC, and those with N17K and
A25M NC mutants. The six lanes for each set were reactions stopped after 2, 4, 8, 16, 32,
and 64 min from left to right. Graphs of efficiency of strand transfer versus time for
different NC mutants are shown in Figs. 2-31 through 2-33. Graphs were made from
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quantification of experiments as described under “Methods”. All the mutants enhanced
transfer considerably compared to reactions without NC. However there was clearly less
enhancement, especially at early time points, in comparison to wt NC. Mutants
F16W/I24Q, F16W/I24Q/N27D and F16W/N27D showed lesser stimulation than wt NC
(Figs. 2-29, 2-30 and 2-31). Mutants N17K, A25M and F16W were comparable to wt NC
with N17K showing slightly more stimulation (Figs. 2-27 and 2-32). Mutants I24Q and
N27D were less stimulatory than wt NC with N27D showing the lowest stimulation
(Figs. 2-28 and 2-33). Again, the differences were more evident at the early time points.
The results indicated that even the mutants which show low helix-destabilizing activity
enhance strand transfer considerably on this highly structured substrate. However, those
with near wt NC levels of unwinding activity showed more stimulation.
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Figure 2-23: Schematic model of strand transfer assay
Shown is a schematic diagram of the strand transfer system. The donor and acceptor
RNAs were derived by PCR amplification of the gag-pol frameshift region. The 5’end of
the 20 nucleotide primer (complementary to the donor) was radio-labeled with P-32 and
is indicated with an asterisk symbol. The donor and acceptor RNAs were 175 and 177
nucleotides (nt) in length, respectively. They are homologous only in the boxed region
which spans 150 nt. Full length DNA synthesized on the donor RNA template is
indicated by dotted lines. Transfer DNA synthesized on the acceptor RNA template is
indicated by broken lines. Note that the donor-directed DNA product is shorter in length
in comparison to the transfer DNA product (Figure obtained from Derebail et al. [135] ).
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Figure 2-24: Schematic of experimental approaches used
Shown is a schematic diagram illustrating experimental approaches used in the strand
transfer assay. The donor and acceptor DNAs (dark green) were derived by PCR
amplification using forward and reverse primers (black) from the gag-pol frameshift
region of the pNL4-3 plasmid (pink). In vitro RNA transcription was then conducted
using SP6 RNA polymerase to get donor and acceptor RNA templates (only donor RNA
is shown in light green). A 5’ P-32 end-labeled DNA primer (pink line with asterix
symbol) synthesized DNA on the donor RNA (primer was complementary to the donor
only). The primer/donor hybrid was used in several time course reactions in the presence
of acceptor RNA. –NC represents a reaction in which no NC was present. wt NC
represents a reaction carried out with wt NC. NC mutant [1….n] represents reactions
carried out with all the NC mutants.
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Figure 2-25: Predicted secondary structure of gag-pol donor RNA template
RNAdraw and mfold programs were used to predict the secondary structure of gag-pol
donor RNA template at 37ºC and default conditions. Concentric circles indicate the
5’end. The substrate is 155 nt in length (excluding the first 20 nt that bind to the DNA
primer). Base-pairs having a greater probability of formation are denoted by thicker lines.
The ∆G value of unfolding is also indicated. 77 besides a boxed A residue denotes the
major RT pause site. SS within a box denotes the “slippery site” heptamer sequence
(Figure obtained from Derebail et al. [135]).
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Figure 2-26: Predicted secondary structure of gag-pol acceptor RNA template
RNAdraw was used to predict secondary structure of the gag-pol acceptor at 37ºC and
default conditions. As before, concentric circles indicate the 5’end. The ∆G value of
unfolding is also indicated. Boxed G residues denote T1 RNase cleavage sites. Diamond
A/U residues denote RNase A cleavage sites. The major pause site for RT (A residue) is
also denoted (Figure obtained from Derebail et al. [137]).
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Figure 2-27: Autoradiogram of strand transfer assay with N17K and A25M
An autoradiogram of a strand transfer assay carried out with the N17K and A25M
mutants is shown. The assay was performed as described under “Methods”. The four sets
of assays shown from left to right were reactions carried out without NC, with wt NC,
and those with N17K and A25M mutants. Aliquots from each reaction were stopped at 2,
4, 8, 16, 32, and 64 min and analyzed on an 8% denaturing polyacrylamide gel. Positions
of the donor-directed and transfer products and the primer are indicated by D, T, and P
respectively. C represents a control reaction in which no acceptor/RT/NC is present.
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Figure 2-28: Autoradiogram of strand transfer assay with N27D and I24Q
Shown is an autoradiogram obtained from a strand transfer assay performed with N27D
and I24Q NC mutants. The assay was carried out as described above.
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Figure 2-29: Autoradiogram of strand transfer assay with F16W/I24Q
Shown is the autoradiogram obtained from a strand transfer assay carried out with the
F16W/I24Q NC mutant. The experiment was performed as described earlier.
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Figure 2-30: Autoradiogram of strand transfer assay with F16W/I24Q/N27D and
F16W/N27D
Shown is the autoradiogram obtained from a strand transfer assay with
F16W/I24Q/N27D and F16W/N27D NC mutants. The assay was carried out as described
earlier.
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Figure 2-31: Graph showing efficiency of strand transfer versus time for
F16W/I24Q, F16W/I24Q/N27D and F16W/N27D
Graph of efficiency of strand transfer versus time for F16W/I24Q, F16W/N27D and
F16W/I24Q/N27D NC mutants is shown. The graph was made from quantification of the
experiments shown earlier. The % efficiency of strand transfer was obtained using the
following formula: Transfer DNA products (T)/ {Transfer DNA products (T) + Full
length donor-directed DNA products (D)}* 100, or ([T/ (T+D)]*100). It was then plotted
against time in min.
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Figure 2-32: Graph showing efficiency of strand transfer versus time for N17K,
A25M and F16W
Graph of efficiency of strand transfer versus time for N17K, A25M and F16W NC
mutants is shown. The graph was plotted as described earlier.
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Figure 2-33: Graph showing efficiency of strand transfer versus time for N27D and
I24Q
Graph of efficiency of strand transfer versus time for N27D and I24Q NC mutants is
shown. The graph was plotted as described earlier.
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Table 2-5
Sequence of forward and reverse primers used for PCR amplification of the gag-pol
region
Region Primer sequences
a. 5' gatttaggtgacactatagatatagaaatgtggaaagga 3'
GagPol donor b. 5' ttgttgtctctaccccagac 3'
a. 5' gatttaggtgacactatagtatatcccctaggaaaaagggctgt 3'
GagPol acceptor b. 5' ctgaagctctcttctggtgg 3'
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2.7 Discussion
In this report we attempt to understand at an amino acid level why zinc finger one
is more important than finger two to the helix destabilizing activity of HIV-1 NC (See
Sec 2-1). The approach used was to make mutations in finger one using the
corresponding amino acids in finger two (See Fig. 1-7). Five of the 14 total amino acids
in each finger are different. Of the 5 changes, three of them represent a significant
chemical alteration including two neutral to charge changes: (finger one to two) N17 to
K38 and N27 to D48, and a hydrophobic to polar change: I24 to Q45. The other two are
amino acids of similar hydrophobicity with those in finger 2 being more bulky: F16 to
W37 and A24 to M46. Overall the five changes result in finger one being considerably
more hydrophobic than two. Results showed that only I24Q and N27D mutations
significantly decreased NC’s helix destabilizing activity while A25M caused a small
reduction. The N17K mutation had no measurable effect while F16W imparted greater
helix destabilizing activity on NC. Double and triple mutant combinations with F16W
combined with I24Q and N27D showed that the latter two were “dominant negatives” in
that all the combination mutants were highly defective in both binding DNA and helix
destabilization.
The simple approach of drawing conclusions from altering just these 5 amino
acids partly ignores potentially important context effects. For example, NMR studies
have shown that several interactions occur between finger one amino acids and other
parts of the NC protein during binding to specific HIV stem-loop structures [77], [124],
[44]. These include for example, F16 and N17 interacting with W37, I24 with valine and
phenylalanine residues at positions 13 and 6, respectively, and N17 interacting with
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proline and lysine at positions 31 and 33. Also, recent results implicate finger two in
helix destabilizing as a W37 to leucine mutation in finger two greatly decreased NC
binding to nucleic acids and helix destabilizing activity on the HIV TAR region [138].
Clearly, several interactions between finger one and two, and finger one and non-finger
amino acids in NC are important to its biological functions, however, results suggest they
may be less important to chaperone and helix destabilizing activity. Experiments show
that finger mutants without an active finger two (1.1 or SSHS2) are still potent chaperone
proteins in vitro and retain nearly wt NC helix-destabilizing activity (See Sec 2-1). In
addition, truncated NC proteins missing the first 12 N-terminal non-finger amino acids
(NC 12-55) showed strong helix-destabilizing activity. A double switch mutant in which
F16 is replaced by tryptophan and W37 by phenylalanine retained most of its binding and
helix destabilizing activity on TAR implying that the aromatic nature of the amino acids
rather than a specific residue at a specific position is important to activity [138]. This is
further supported by the high activity of NC 1.1 which has phenylalanine at positions 16
and 37.
The genetic flexibility of NC is further illustrated by cell culture experiments
using mutated viruses. In one report, replacement of finger one with 7 different zinc
fingers from a family of human cellular nucleic acid binding proteins (CNBPs) resulted
in infectious viruses in 6 of the 7 cases [139]. In another report, alanine scanning
mutagenesis was performed on finger one [140]; excluding F16 and the four amino acids
that are part of the zinc binding motif (C15, C18, H23, and C28), alanine mutagenesis of
the other 9 amino acids (in one case alanine 25 was changed to glycine) produced viruses
with essentially wt NC infectivity that in some cases showed mild to moderate RNA
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packaging defects. Although F16A was defective, an F16W mutant was comparable to wt
virus, a result that correlated with our finding that F16W is as good as or better than wt in
helix destabilization and strand transfer. In the F16W mutant, phenylalanine gets replaced
with a more bulky amino acid namely tryptophan. Perhaps this enables it to intercalate
between nucleic acid bases even better, thereby resulting in enhanced chaperone activity.
This could also explain why A25M exhibits similar or slightly diminished unwinding
activity with structured substrates in comparison to wt NC, since methionine is also a
more bulky group than alanine. Also interesting with respect to our results was the
finding that N27 could be changed to alanine with little effect on infectivity. Although
this position is fairly highly conserved, HIV isolated with serine, histidine, isoleucine,
and tyrosine at this position have been reported (HIV genome sequence information was
obtained from the HIV sequence database provided by Los Alamos National Laboratory
(http://hiv-web.lanl.gov/content/hiv-db/mainpage.html)). The N27D mutant in our studies
was quite defective in DNA binding and helix destabilization, but this is a much more
drastic change than those changes noted above. The NC protein of the virus used in the
above study had a threonine at position 24 rather than isoleucine as is present in the strain
we used, but the fact that it could be changed to alanine without loss of infectivity
suggests some flexibility at this position. This position is not as strongly conserved as the
other 4 examined in our assays. Many HIV isolates have leucine at this position and
some have threonine and valine. The I24Q and an I24E (glutamic acid) mutant that we
also tested (Data not shown) were quite defective in helix destabilization and the latter
bound DNA poorly. Perhaps there is a limit to how polar the amino acid at this position
can be. Isoleucine 24 along with V13, F16, and A25 have been implicated as part of an
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important hydrophobic cleft in finger one that is required for binding and destabilizing
nucleic acids [107]. The fact that some virus strains have threonine at position 24 and that
alanine can be substituted without loss of viability suggests that the amino acid at this
position need not be highly hydrophobic. It is also possible that NC proteins with reduced
helix destabilizing activity may be functional during infection. The NC protein of
Moloney murine leukemia virus (MuLV) has very little helix destabilizing activity in in
vitro assays [130] and it seems unlikely that the 6 functional fingers from the human
CNBP proteins (See above) would all have high destabilizing activity. Therefore it is
possible that HIV-1 NC could get by with less, as long as other important NC functions
were not compromised. We are in the process of testing the mutants made in these
experiments in the context of cellular infections. Preliminary experiments suggest that
there is no defect in replication with N27D mutant viruses in H9 cells (Data not shown);
supporting the hypothesis that reduced helix destabilizing activity is not detrimental to
virus fitness. It would also be interesting to test the helix destabilizing activity of viable
mutations at position 24 as well.
The N17K mutation tested here has also been examined in cell culture infections
[141]. Interestingly, viruses with this mutation show no replication defects and actually
have a 7-9 fold increased transduction frequency compared to wt NC. In addition to
packaging viral RNA better than wt NC, there was also an increased packaging of non-
viral RNA. Several other mutations in the finger amino acids that increased net positive
charge of the fingers also lead to viable viruses with transduction levels as good as or
better than wt NC. The N17K mutation was essentially equivalent to the wt NC in all the
assays we tested it in so it is not surprising that it would function well. Despite this,
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BLAST searches recovered no isolated viruses with N17K mutations, suggesting that this
change is selected against in vivo [141].
The strand transfer assays were reasonably consistent with helix-destabilization
assays in that those mutants defective in the latter generally showed some decrease in
strand transfer. Mutant N27D and the double and triple mutants (F16W/N27D and
F16W/I24Q/N27D) containing this mutation appeared to be the most defective while
I24Q and F16W/I24Q were moderately less stimulatory than wt NC (See Sec 2-6). The
other point mutants were essentially the same as wt NC with N17K showing a small
enhancement. The gag-pol genome region used in the assays is highly structured [135]
and it seems surprising that all the mutants, even the double and triple mutants and N27D
which were highly defective in helix-destabilization and DNA binding, showed a clear
enhancement. However, previous assays with finger mutant 2.2, which is highly defective
in helix destabilization assays (Tables 2-2, 2-4 and [91]), showed stimulation of strand
transfer on the gag-pol substrate, albeit at a reduced level compared to wt NC. In
addition, 2.2 was essentially identical to wt for stimulation on a low-structured substrate
[135]. These results suggest that the aggregation/condensation activity of NC, which all
the mutants appeared to retain (See Sec 2-4), is a major driving force for strand transfer
while helix destabilization may be less important, especially in low structured genome
regions.
From our results, the most important amino acid differences between finger one
and two with respect to chaperone activity are I24Q and N27D. Both are extreme
chemical changes that strongly decrease the hydrophobic nature of finger one. The
overall more hydrophobic nature of finger one could be important to its apparent
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advantage for helix destabilization. On a mechanistic level, mutant N27D caused a large
defect in nucleic acid binding and this alone could have been responsible for its low
activity. Low binding may have occurred from repulsion of nucleic acids by the
additional negative charge of the aspartic acid side chain or a dramatic change in protein
folding. The latter is unlikely since viral clones with this mutation showed no defect in
replication in H9 cells (See above). Mutant I24Q did not significantly alter nucleic acid
binding. This could be due to the neutral nature of glutamine which probably did not alter
the charge density at that position. This suggests that no deleterious change in overall
structure had occurred. However, perhaps by decreasing the hydrophobicity of finger one,
substitution of glutamine for isoleucine reduces NC’s ability to interfere with
hydrophobic base stacking. This would be consistent with the previously proposed role of
the hydrophobic pocket of finger one (See above, [138])
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Chapter 3 Analysis of the nucleic acid chaperone activity of other
retroviral NC proteins
3.1 Introduction
Retroviral nucleocapsid (NC) proteins are very small, basic proteins that coat the
genomic RNA. They act as molecular chaperones during several steps in the viral
replication cycle. They catalyze transitional unfolding and re-pairing of nucleic acids
such that the optimal conformation with maximum number of base pairs is attained.
Previous chapters dealt with in-depth analysis of nucleic acid chaperone activity of HIV-
1 NC. Work done in this chapter sheds light onto helix-destabilizing activity of other
retroviral NC proteins. These include those from Moloney murine leukemia virus (MuLV
NC), the Mne strain of Simian immunodeficiency virus (SIV NCp8), HIV-1 NCp15 and
HIV-1 NCp9. HIV-1 NCp15 is first produced as a result of proteolytic cleavage from the
Gag precursor polyprotein. NCp9 results due to further cleavage from NCp15. This is
further cleaved to just under 7 kDa to yield the functional NC protein used in previous
chapters [1].
Table 3-1 lists amino acid sequences of the various NC proteins used in this
study. SIV belongs to the Lentivirus genus of retroviruses. The nucleocapsid protein of
SIV (SIV NCp8) is 52 amino acids in length and has two zinc fingers. Each zinc finger is
14 amino acids in length and coordinates one Zn2+ ion. Each finger has a Trp residue. A
wealth of information about several properties of SIV NCp8 has been obtained through
mutational studies and in vitro assays. Finger mutations in SIV NCp8 have revealed that
lack of zinc coordination affects its stability and interferes with processing of the Gag
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precursor polyprotein [142]. In another vaccine study, a group of Macaca nemestrina
primates were first infected with a pathogenic wt strain of SIV NCp8. This was then
followed by immunization with DNA that produces replication defective yet structurally
complete virions. These virions were obtained from NC deletion mutant clones and
contained a full set of processed viral proteins capable of completing nearly all the steps
during one viral replication cycle. This appears to offer protection or at least delay
progression onto AIDS [143]. In one other study, four amino acids were deleted in the
carboxyl terminal zinc finger of SIV NCp8, producing non-infectious viruses (though
capable of completing most of the steps in viral replication). Immunization with DNA
expressing this NC mutant provided substantial humoral immunity [144]. In one
experimental study with macaques, no antibody production/disease progression was
observed. Gorelick et al. have demonstrated that mutations in both zinc fingers of SIV
Mne NC produce replication defective virions both in vitro and in vivo. The basic
residues found in SIV NC have been shown to be very crucial for incorporating genomic
RNA. However, RNA encapsidation in SIV was found to depend more on finger two
rather than finger one as is the case in HIV-1 [145]. Optically detected magnetic
resonance (ODMR) studies have revealed that both the zinc fingers of SIV NCp8 bind
simultaneously to oligonucleotides, and were found to contribute to its binding free
energy, though not additively. Significant quenching of fluorescence from both Trp
residues suggests that hydrophobic stacking occurs between the indole ring and
nucleobases. The binding order of preference was similar to that of HIV-1 NC namely:
G ~ I (Inosine) > T > U > C > A. SIV NCp8 bound to alternating bases in a sequence-
specific manner similar to HIV-1 NC [146]. NMR studies conducted with the zinc finger
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domains (amino acids 13-51) of SIV NCp8 have revealed that the main structural
differences between SIV NCp8 and HIV-1 NC occur at the flexible linker and not the
zinc fingers. However, orientation in which the two proteins interact with
oligonucleotides was found to be quite similar [147].
Murine leukemia virus belongs to the gammaretrovirus family. MuLV NC is 60
amino acids in length and is located at the C-terminus of Gag. It is produced as a result of
proteolytic cleavage from Gag upon maturation. It contains only one zinc finger motif.
Mutational studies with MuLV NC have revealed that it stimulates DNA synthesis by RT
at pause sites [148]. Experiments done with MuLV NC zinc finger mutants CCCC or
CCHH have shown that these mutations do not affect RNA recognition, t-RNA primer
placement, RNA packaging and dimer RNA structure. However, they do seem to greatly
affect cDNA synthesis and hence produces non-infectious virions defective in replication
[149], [150]. Further, NC native zinc finger architecture was found to be critical for
replication events preceding integration and possibly viral integration itself. In one study,
when all the cysteine residues were replaced with serines, RNA packaging was greatly
reduced. Gorelick et al. also point out that this sequence is fairly conserved across
retroviral NC proteins and could be related evolutionarily to the zinc fingers that are
involved in specific sequence recognition in double stranded DNA [79]. Further, Rein et
al. have also shown through mutational studies that a central region of MuLV NC
consisting of residues 16 through 23 is critical for RNA packaging. This region is
followed by the zinc finger’s cysteine array and flanked by basic residues. Further, the
basic region and zinc finger have also been demonstrated to be critical for assembly and
release of virus particles [151]. D’Souza et al. have shown that unlike HIV-1 NC, the
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binding affinity of MuLV NC to the stem loops found in its genomic RNA is quite low
[152]. Allain et al. have shown that the basic residues and not the zinc finger in MuLV
NC is critical for enhancing the minus strand transfer step during reverse transcription
[153]. Single molecule stretching experiments and mutational studies have been carried
out to evaluate the chaperone activity of HIV-1 and MuLV NC. Results have shown that
HIV-1 NC but not MuLV NC lowers the cooperativity of DNA helix-coil transitions.
Since this is a measure of helix-destabilizing activity it suggests that HIV-1 NC has more
potent destabilizing activity. Also consistent with this finding, Williams et al. point out
that a specific two finger architecture is most likely required for unwinding and hence
optimal chaperone activity during viral reverse transcription. Overall the findings suggest
that MuLV can efficiently replicate with an NC protein possessing little helix-
destabilizing activity in comparison to HIV-1 [130].
Finally, compounds that oxidize sulfur atoms by inducing disulfide cross linking
in cell-free MuLV virions have been identified [154]. This effect has also been observed
in HIV-1 but not in HFV virions (Human Foamy Virus) [155]. It should be noted that
HFV belongs to the Spumaretrovirus genus of retroviruses which lack zinc fingers. Thus,
the zinc finger of MuLV NC forms the primary target for these anti-retroviral
compounds. Other zinc ejecting compounds that potently inhibit HIV-1 through NC
deactivation are also being tested [155]. Further studies on NC proteins could potentially
lead to more and better inhibitors for use as potential therapeutics.
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3.2 Materials
DNA oligonucleotides for the fluorescence resonance energy-transfer (FRET)
assays were purchased from Integrated DNA Technologies (Coralville, IA). See Chapter
2 for a list of other materials used. All of the chemicals were purchased from Sigma
Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA).
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3.3 Methods
FRET assay to detect DNA/DNA annealing: Refer to Chapter 2 for details.
Preparation of HIV-1 wt NC: Wild-type HIV-1 NC from either the MN strain
(GenBank accession number: M17449), the ARV strain or pNL4-3 was used in this
study. Wild-type MN NC was expressed and purified as described [136]. The construct
that expresses wild-type ARV NC (GenBank accession number: K02007) was graciously
provided by Dr. Charles McHenry (University of Colorado) and this protein was prepared
as described previously [107]. Wild type NC protein from the pNL4-3 sequence
(GenBank accession number AF324493) was prepared essentially as described [75]. The
three wt NC proteins differ by no more than five amino acids, which are all functionally
conserved (See Table 3-1). SIV NCp8, MuLV NC, NCp9 and NCp15 proteins were
kindly provided by Dr. Robert J. Gorelick, SAIC, Frederick, MD. NC aliquots were




Annealing assays performed with wt NC and other retroviral NC proteins: FRET
annealing assays were performed as described in Chapter 2 with the 0.0, 5.8 and 9.0dna
substrates. However, while the assay was carried out for 4 min as before with the 5.8dna,
the annealing was monitored for only 1 min with the 0.0dna. This was done due to rapid
annealing kinetics of the non-structured substrate as most of the annealing was completed
within the first min of the time course reaction. Five retroviral NC proteins were tested
for their annealing activity. These include MuLV NC, SIV NCp8, HIV NCp9, HIV
NCp15 and wt HIV-1 NC (NCp7). Figure 3-1 and Table 3-2 summarize the results
obtained from annealing assays carried out with 0.0dna. Rate constants for complement
annealing were calculated as described earlier. With the unstructured substrate,
complementary nucleotides annealed very rapidly even in the absence of NC, and NC
clearly enhanced annealing even further resulting in about a 2-fold increase in the rate
constant. This demonstrates NC’s ability to enhance annealing even in the absence of
secondary structure, presumably by aggregation/condensation. While MuLV NC and
NCp9 showed no stimulation on 0.0dna, SIV NCp8 appeared to retain some
aggregation/condensation activity based on this assay. NCp15 stimulated annealing close
to wt NC levels. This is consistent with the idea that this activity results mostly from the
highly positively charged NC backbone amino acids that act to neutralize negative
charges on the phosphate backbone of nucleic acids.
Figure 3-2 and Table 3-3 show the effect observed with various NC proteins on
5.8dna. On this more strongly folded substrate clear groupings emerged. NCp15 was able
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to stimulate annealing as well as wt NC. SIV NCp8 showed reduced annealing in
comparison to NCp15, but was clearly better than MuLV NC. MuLV NC showed about a
60-70% rate reduction in comparison to wt HIV-1 NC. Interestingly, NCp9 facilitated
annealing was nearly 2-fold greater than wt HIV-1 NC (Fig. 3-2 and Table 3-3). The
same general pattern was observed with the strongest structure, 9.0dna (Fig. 3-3 and
Table 3-4). In this case annealing was much slower than with 5.8dna (approximately 4-7
fold) reflecting greater stability of the substrate; and the assay was performed over 16
min rather than 4 min as with 5.8dna. Very little annealing was observed in reactions
without NC and no rate values were obtained. Once again NCp15 was similar to wt HIV-
1 NC. SIV NCp8 showed some reduction in annealing. No detectable stimulation was
observed with MuLV NC. Again, NCp9 stimulated annealing better than wt HIV-1 NC
showing about a 2-fold increase (Fig. 3-3). Shown in Tables 3-3 and 3-4 are the rate
constants for NC proteins on structured DNA substrates (5.8dna and 9.0dna). Annealing
assays with SIV NCp8 and MuLV NC on 9.0dna were also carried out using reduced salt
conditions. As expected, the rate of annealing increased by nearly 2-fold at 40 mM KCl
and even higher; by nearly 4-fold at 20 mM with SIV NCp8. The effect of low salt buffer
was even more pronounced in case of MuLV NC. The observed rate constant increased
by nearly 4-fold and 7-fold at 40 mM and 20 mM KCl, respectively (Table 3-4).
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Figure 3-1: FRET assay with retroviral NC proteins on 0.0dna
Shown above is the FRET assay performed with the five retroviral NC proteins on
0.0dna. C denotes a control reaction in which no complementary DABCYL DNA was
present. –NC denotes a reaction in which no NC was present. The assay was carried out
as described previously except that the annealing reaction was monitored for only 1 min
(See Chapter 2).
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Figure 3-2: FRET assay with retroviral NC proteins on 5.8dna
Shown above is the FRET assay performed with the five retroviral NC proteins on
5.8dna. C denotes a control reaction in which no complementary DABCYL DNA was
present. –NC denotes a reaction in which no NC was present. The assay was carried out
as described previously (See Chapter 2).
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Figure 3-3: FRET assay with retroviral NC proteins on 9.0dna
Shown above is the FRET assay performed with the five retroviral NC proteins on
9.0dna. C denotes a control reaction in which no complementary DABCYL DNA was
present. –NC denotes a reaction in which no NC was present. The assay was carried out
as described previously (See Chapter 2).
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Table 3-1


































1- The three wt HIV-1 NCp7 proteins used in this assay differ by no more than five
amino acids (highlighted in yellow), which are all functionally conserved. Amino acid
sequences of other retroviral proteins namely SIV NCp8, MuLV NC, NCp9 and
NCp15 proteins are also shown. Finger domains of all NC sequences are highlighted in
pink.
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Table 3-2. Rate constant calculation for NC
proteins on 0.0dna substrate
1Name 2t1/2(min)
2k*10-3(min-1)
-NC 1.27 0.549 ± 0.046
wt NC 0.598 1.16 ± 0.049
MuLV NC 1.53 0.469 ± 0.119
SIV NCp8 0.956 0.732 ± 0.102
NCp9 1.47 0.478 ± 0.077
NCp15 0.797 0.870 ± 0.024
1-HIV strain MN NC was used in these assays and
was prepared essentially as described (See Methods).
All of the other retroviral proteins were a kind gift of
Dr. Robert J. Gorelick, SAIC, Frederick, MD.
2-k (rate constant) values were calculated from the t1/2
values by dividing 0.693 by t1/2 as described. Results are
an average of 2-3 experiments ± standard deviations
(shown for k only).
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Table 3-3. Rate constant calculation for NC
proteins on 5.8dna substrate
1Name 2t1/2(min)
2k*10-3(min-1)
wt NC 4.31 0.161 ± 0.005
MuLV NC 23.3 0.030 ± 0.005
SIV NCp8 8.67 0.080 ± 0.009
NCp9 1.90 0.364 ± 0.006
NCp15 3.06 0.229 ± 0.029
1-HIV strain MN NC was used in these assays and was
prepared essentially as described (See Methods). All of
the other retroviral proteins were a kind gift of
Dr. Robert J. Gorelick, SAIC, Frederick, MD.
2-k (rate constant) values were calculated from the t1/2
values by dividing 0.693 by t1/2 as described. Results are
an average of 2-3 experiments ± standard deviations
(shown for k only).
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wt NC 29.2 0.024 ± 0.001
MuLV NC 834 0.001 ± 0.001
SIV NCp8 42.7 0.016 ± 0.002
NCp9 13.6 0.052 ± 0.010
NCp15 19.4 0.037 ± 0.009
MuLV NC (20 mM KCl) 151 0.005
MuLV NC (40 mM KCl) 197 0.004
SIV NCp8 (20 mM KCl) 9.80 0.071
SIV NCp8 (40 mM KCl) 17.9 0.039
1-HIV strain MN NC was used in these assays and was prepared
essentially as described (See Methods). All of the other retroviral
proteins were a kind gift of Dr. Robert J. Gorelick, SAIC, Frederick, MD.
2-k (rate constant) values were calculated from the t1/2 values by dividing
0.693 by t1/2 as described. Results are an average of 2-3 experiments
± standard deviations (shown for k only for 80 mM KCl assays).
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3.5 Discussion
In this work, we wished to analyze the helix-destabilizing activity of other
retroviral NC proteins namely SIV NCp8 and MuLV NC, and two precursor forms of wt
HIV-1 NC; NCp9 and NCp15. MuLV NC has only one zinc finger motif. Moreover, it
does not bind tightly to RNA stem loops under in vitro conditions [152]. Single molecule
stretching experiments have shown that it does not lower the cooperativity of DNA helix-
coil transitions, even at saturating levels, whereas HIV-1 NC exhibits optimal chaperone
activity at a much lower concentration. Also Williams et al. point out that the differences
between the two proteins could be due to differential binding affinities with HIV-1 NC
binding much more tightly. Further, it is also possible that MuLV NC does not require
unwinding activity for stimulating minus-strand transfer under in vivo conditions, while
HIV-1 NC does. In vitro strand transfer assays conducted using MuLV NC in the HIV-1
R region and DNA stretching studies conducted by Williams et al. augment this
hypothesis. However, it should be noted that the secondary structure element that has to
be unwound in order to facilitate MuLV minus strand transfer is much less stable than the
highly structured HIV-1 TAR region. Therefore MuLV may not need as much
destabilizing activity to carry out this process [130].
MuLV NC was found to be highly defective in helix-destabilization in
comparison to wt NC in our assays (Figs. 3-2, 3-3 and Tables 3-3, 3-4). This correlates
with the findings of Williams et al. described above [130]. It is worthwhile to note that
the single finger of MuLV NC more closely resembles finger two of HIV-1 NC in that it
has an aspartic acid residue in the same location as finger two of HIV-1 NC (See Fig. 3-
1). Earlier helix-destabilization studies conducted with HIV-1 NC showed that replacing
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asparagine with this residue was severely detrimental to its helix-destabilizing activity. It
should also be noted that the N27D mutant was defective in nucleic acid binding and in in
vitro strand transfer assays (See Chapter 2). It is reasonable to hypothesize that this
amino acid residue could be partly responsible for MuLV NC’s diminished nucleic acid
binding and hence unwinding properties. Annealing assays conducted with non-
structured and structured substrates show that MuLV NC is highly defective in both
aggregation and unwinding.
SIV NCp8 exhibits reduced annealing as well; however it is clearly better than
MuLV NC. The difference in annealing rates between SIV NCp8 and wt HIV-1 NC was
nearly two fold (See Tables 3-3 and 3-4). It can be seen that SIV NC p8 shares high
homology with HIV-1 NC especially in the zinc finger residues (See Table 3-1). Once
again, it did not exhibit any defects in nucleic acid aggregation (See Table 3-2).
Further, while NCp15 enhances annealing close to wt HIV-1 NC levels, NCp9
was found to be better than wt HIV-1 NC (See Tables 3-3 and 3-4). The observed
differences between NCp15 and NCp9 could be due to the presence of additional
glutamine and glutamic acid residues in NCp15 (See Table 3-1). The isoelectric point (pI)
values for wt HIV-1 NC, NCp9 and NCp15 were found out to be 10.08, 10.19 and 9.59
respectively (All pI values were obtained from ExPASy Proteomics Server of the Swiss
Institute of Bioinformatics (SIB)). Upon comparing the pI values, it can be seen that
NCp9 adds higher net positive charge. This could have minimized electrostatic repulsion
between the phosphate groups of nucleic acids during annealing. Also, it should be noted
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that NCp9 was defective in the aggregation assay with 0.0dna. It is not clear what causes
this apparent reduced aggregation activity of NCp9. Clearly, further studies are needed to
fully understand the various structure-function relationships of these proteins.
Finally, low salt (20 mM and 40 mM KCl) conditions were used to gain insight
into the duplex-stabilizing properties of SIV NCp8 and MuLV NC (See Tables 3-2 and 3-
4). Optimal Mg2+ concentrations (6 mM) for reverse transcriptase assays were used in the
above described experiments. As expected, under high salt conditions, higher screening
of duplexes is brought about by high salt/multivalent cations. Thus, more effective
annealing in the absence of a catalyst under high salt conditions most likely accounts for
the weaker effect of NC enhanced annealing under low ionic strength conditions. The
observed rate enhancement facilitated by NC is hence more pronounced under low ionic
strength conditions, since there are less competing cations to displace NC [82]. A similar
effect was observed in the annealing rates which increased by a huge factor, about 3-4
fold with lower Mg2+ (1 mM) concentration in the annealing assays performed earlier
with HIV-1 NC mutants (See Chapter 2). However, the concentration of non-complexed
Mg2+ in cells may be much lower [156] and results have shown that NC is more active
with lower ionic strength [55]. This may also occur with MuLV NC and should be tested
in the future.
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Chapter 4 General Discussion
AIDS continues to be the one of the biggest threats facing mankind today. It has
claimed more than 25 million human lives since its discovery in 1981 [6]. The ultimate
goal of researchers worldwide is to develop efficient vaccines and drugs such that this
virus can be eradicated. A thorough understanding of the virus and various steps in its
replication cycle could help achieve this goal. HIV is one of the most recombinogenic of
all retroviruses and has a high mutation rate. This has contributed to the rapid emergence
of several subtypes and now intersubtype recombinant forms of the virus [5]. HIV-1 NC
is a small, basic protein that coats the viral genome. The multitude of functions
performed by this protein has caused it to gain equal importance on par with the three
other classic retroviral proteins namely, reverse transcriptase (RT), integrase (IN) and
protease. Thus, NC has emerged as a prime target for vaccine research and drug therapy.
Obviously, it is of utmost importance to gain an extensive, in depth knowledge about NC;
its structure, various properties and structure-function relationships. The approach used in
this thesis of studying mutated proteins will also help define the genetic flexibility of NC.
If NC is highly tolerant of mutations, as seems to be the case with RT, drug resistant
mutants are likely to emerge during NC targeted therapy.
Work done in this thesis sheds light onto the chaperone activity of HIV-1 NC.
Chaperones are proteins that can catalyze the rearrangement of nucleic acid molecules
such that the most thermodynamically stable conformation is achieved [41]. Chaperone
proteins are found in other organisms as well. These include gene 32 protein found in T4
bacteriophages (T4 gp32), single-strand binding protein in E.coli (E.coli SSB) and
ribonucleoprotein A1 found in humans (hnRNP A1) (For a more compete list see
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http://mendel.imp.ac.at/home/Birgit.Eisenhaber/RNA-chaperones/list.html). However,
HIV-1 NC continues to be the most widely studied chaperone protein.
My thesis attempts to understand at an amino acid level why zinc finger one of
HIV-1 NC is more important than finger two to its helix destabilizing activity (See Sec 2-
1). Five of the 14 total amino acids in each finger are different. The approach used was to
incrementally replace each differing residue in finger one by the one at the corresponding
location in finger two (See Fig. 1-7). The most important amino acid differences between
finger one and two with respect to chaperone activity are I24Q and N27D (See Chapter
2). Overall, NC is quite tolerant of single amino acid changes as even the most defective
single point mutants (I24Q and N27D) retained about 50% helix destabilizing activity
(See Sec 2-4) and nearly full aggregation activity (As judged by assays with the non-
structured substrate). Double and triple mutants were more defective than wt NC but still
retained measurable activity (See Sec 2-4). The high genetic flexibility of NC which is
further illustrated by previous noted experiments showing that replacing the entire finger
of NC with human protein zinc fingers in most cases did not abolish infectivity [139].
The unfortunate likelihood is that viable mutants would arise easily upon drug NC
directed drug treatments. Still such drugs could be very useful in combination therapy
with drugs targeting other proteins.
Also as discussed previously in Chapter 2, interesting with respect to our results
was the finding that N27 could be changed to alanine with little effect on infectivity
[140]. Although this position is highly conserved, HIV isolated with serine, histidine,
isoleucine, and tyrosine at this position have been reported (HIV genome sequence
information was obtained from the HIV sequence database provided by Los Alamos
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National Laboratory (http://hiv-web.lanl.gov/content/hiv-db/mainpage.html)). The N27D
mutant in our studies was quite defective in DNA binding and helix destabilization, but
this is a much more drastic change than those changes noted above. Further, as mentioned
earlier, the N27D mutant was not found to be defective in replication in vivo in H9 cells.
Based on the very low helix destabilizing activity of N27D in vitro, it seems reasonable
to hypothesize that the aggregation activity of HIV-1 NC is more critical than helix-
destabilizing activity for viral viability. Preliminary results suggest that this may be the
case for retroviruses in general as NC proteins from SIV show reduced destabilizing
activity and MuLV NC shows very little (See Chapter 3). It is important to note here that
the apparent ability of viruses containing the N27D mutation to replicate in cells does not
mean that defects would not become apparent after several rounds of replication, or that
the mutant is as fit as wt virus. Competition growth assays between the mutant and wt
NC would have to be performed to assess relative fitness of the mutant.
Since NC is involved in several steps of the viral life cycle, a comprehensive
analysis of how it works could enable us to potentially figure out new ways to target this
protein. Designing molecules/compounds like nucleic acid analogues which would bind
tightly to NC and prevent it from interacting with nucleic acids does seem like a
promising avenue of research. A number of NC inhibitors have been proposed and some
are undergoing initial phases of clinical trials. It is very probable that drug-resistant
mutants would appear which are able to circumvent these drugs. Identifying amino acid
residues that are invariant, would give us an idea of which ones are indispensable for
viral viability. Among the two residues that were found to contribute significantly to
HIV-1 NC’s destabilizing activity, the asparagine residue at position 27 was found to be
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fairly highly conserved and hence could be considered as generally invariant. If NC
inhibitors could be designed that can specifically bind/disrupt this residue, perhaps the
destabilizing activity of NC can be disturbed. In one report, threonine at position 24 of
HIV-1 NC was changed to alanine; resulting in no loss in infectivity [140]. It should be
noted that this NC protein had a threonine at position 24 rather than isoleucine as is
present in the strain we used, but the fact that it could be changed to alanine without loss
of infectivity suggests some flexibility at this position. This position is not as strongly
conserved as the other four examined in our assays. Many HIV isolates have leucine at
this position and some have threonine and valine. If these NC isolates could be examined
in vitro and tested for their destabilizing and aggregation activities, we can possibly gain
further insight into the apparent flexibility at this position. One possibility that is
suggested by the viability in cells with the N27D mutation is that NC needs relatively
little helix destabilizing activity to complete replication. Since many of the naturally
occurring HIV isolates that have been sequenced have residues other than isoleucine at
position 24, it would be interesting to test these isolates for helix destabilizing activity. If
lower (or higher) activity is found this would suggest that the virus can survive with a
variable level of helix destabilizing activity and this activity may not be a major
determinant of viral fitness. With regard to position 24, we also test a glutamic acid
mutant at this position (I24E, data not shown). This mutant was highly defective, even
more so than the F16WI24QN27D triple mutant. The severe change of a hydrophobic to
a negatively charged polar amino acid essentially produced a dead protein illustrating that
this position is not completely flexible.
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Despite over twenty years of intensive laboratory and clinical research, AIDS
continues to be one of the world’s deadliest scourges. In the US alone, AIDS has claimed
more than 400, 000 human lives and continues to be the third leading cause for mortality
between the ages of 25-44, resulting in nearly 10,000 deaths every year. Since 1981,
more than 25 million people worldwide have died of AIDS. Statistics reveal that at the
end of 2005, a staggering 39 million people worldwide were living with HIV/AIDS.
Globally, AIDS is the leading cause of deaths among infectious diseases and is the fourth
leading cause of worldwide mortality. Every year nearly 2.6 million people worldwide
die of AIDS [6]. Intensive research has had a great deal of benefits and has caused US
AIDS related deaths to drop by nearly 80% since its peak at 1991, but of late; results
from recent drug-therapy/vaccine trails are not so promising [157]. Recently, mutant
strains resistant to triple drug therapy have been reported. The main challenges towards
designing effective vaccines/drugs are the high recombinogenic potential and mutation
rates of the virus. With no effective cure in sight, an exhaustive understanding of specific
interactions occurring during viral replication could provide worthwhile information
which can be used in the design of new means of fighting HIV. Work done in my thesis
has given new insight towards understanding intricate mechanisms behind HIV
replication and recombination. Molecular mechanisms behind interaction of HIV-1 NC
with nucleic acids are also investigated in great detail. It also enhances one’s perspective
of how HIV-1 NC facilitates replication and recombination at an amino acid level. As
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